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Institutional Review Board for the Protection of 
Human Subjects (IRB) 
COVID-19 Guidance for Human Subjects Research 
Researchers conducting research with human subjects are 
encouraged to design their st udies to be conducted remotely if at all 
possible as this is the safest approach for our research participants, 
researchers and the univers ity community. For those studies which 
cannot be conducted remotely, face-to-face human subjects research 
may be allowed it is determined that it can be conducted safely, and 
must at al l t imes be in compliance with current directives and 
guidance available on the UMS Informat ion ~g~ and the UMaine 
Information ~g~. The University remains in Research Activity 
Category 'Lower Level (Mid-Late Phase 3) for Human Subjects 
Research (HSR), but the guidance has been updated. The full 
guidance for HSR is available at COVID-i19 Guidance for 
Researchers. 
Updated 9113121 
Submit new applications or modifications to: u mric@maine.edu 
Federalwide Assurance#: FWA00000479 
IRB Organization (IORG) #: IORG0000642 
Students, employees, and agents of the University who conduct research involving human 
subjects must comply w ith the University Policy and Procedures for the Protection of 
Human Subjects of Research. These procedures exist for the rights and welfare of the 
people who participate in UMaine research. No systematic investigation of information 
obtained by observing or interacting with people, or by collecting and examining any form 
of identifiable private information about people, may be conducted until the Protection of 
Human Subjects Review Board has approved the research protocol. 
Contact for IRB Questions 
umric@maine.edu 
Paula Portalatin 
Assistant Director of Research 
Comphance 
Jlaula.P-Qrtalatm@maine.edu 
207.581.2657, 311 Alumni Hall 
Portalatin Bio 
Sandra Caceres Tijerina 
Research Compliance Officer I 
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Guidance & Policy 
Policy 
• Graduate School Polic:y.: Graduate students and faculty advisors, please read section 
10.2.3 (page 43) Human Subjects Approval, from the Graduate School's Policies and 
Regulations. 
• PolicY. Concerning the Protection of Human Subjects of Research (PDF): All persons 
involved with human subjects research shou ld read this policy. 
• Revised common Rules Changes (PDF} 
Guidance 
• Anonymous vs Confidential 
• Continuing Review Instructions: For currently approved (non-exempt) studies. 
• Data EncrY.P-tion Re~uirement: To ensure con fidentiality of identifiable, electronic 
data, the Institutional Review Board (IRB) is riow requiring that the electronic key 
linking participants' identities to their dat a be encrypted. See link for addit ional 
information. 
• De12ression and SuicidalitY. in Human Research - Guidance for Researchers (PD8. 
These guidelines are intended to assist researchers who use measures that screen 
for depression and/or suicidality. 
• Ex12edited Review Categories: Categories of r esearch t hat may be reviewed by the 
IRB through an expedited review procedure. 
• Exem12tion Categories: List ing of research activit ies that may be exempt from further 
review. 
• FERPA Guidance: Consideration when collecting student records 
• Guidelines for Class Projects. These guidelines are intended to assist instructors in 
determining when class projects meet the detinit ion ot research with human 
subjects and require review by the University of Maine's Institu tional Review Board 
for the Protect ion of Human Subjects (i.e., IRB). Please see flow chart (PDF) to assist 
with the decision-making process. Sample of a course SY.llabus (POE) addressing 
class projects (used with permission). 
• Human Subject PaY.ment Guidelines 
• Information about Oral Histo[Y. Activit ies: Informat ion to assist individuals in 
determining when/if oral history activit ies require human subjects review. 
• Informed Consent Guidance/Checklist (PDF}: Information about the informed 
consent process. 
• Inst ructions for Re~uesting a Modification to AP-P-roved StudY. 
• Internal Institutional Data Col lection Guidelines 
• Reactivating a Closed StudY. 
• Referral Handout TemP-late (Word): Use for studies on sensitive topics where 
referrals are required. 
• Sex,_gender, and sexual orientation guidance on demog@P-hic ~uestionnaires 
• What is GDPR? 





















Acknowledgments, by prior agreement between the student and the Graduate Thesis 
Committee. 
5. It is the student’s responsibility to secure copyright permissions when necessary (e.g., 
permission from a journal to use a published paper in the thesis or dissertation). 
6. Programs may choose to develop program-wide guidelines on the use of publications 
in theses or dissertation. 
 
10.2 Approvals Related to Thesis 
 
10.2.1  Thesis Subject 
 
The subject must be formally submitted to the Graduate School at the time the student 
submits the program of study.  Approval of the thesis subject by the student’s advisory 
committee is required. 
 
10.2.2  Completed Thesis 
 
An approved electronic copy of the thesis must be submitted to the Graduate School no 
later than 24 hours before the final examination.  It must have been previously approved 
by a committee which shall be appointed by the Dean of the Graduate School.  The thesis 
shall be read and approved by no fewer than three (3) persons. 
 
The “Tentative Thesis Acceptance Form” signed by the members of the advisory 
committee signifies that the draft thesis has been read and is in appropriate form for the 
oral defense.  The filing of a completed Tentative Thesis Acceptance Form signifies only 
that the student’s committee deems the thesis to be in acceptable form for oral defense.  
A student may expect that revisions, amendments, or additions may be required based 
upon the oral examination.  In rare instances, serious difficulties may be discovered 
during the oral examination, which result in major revisions in a thesis or dissertation.  
(Also see Date of Presentation) 
 
10.2.3  Human Subjects Approval 
 
As required by The University of Maine policy, graduate students who plan to perform 
research that involves the use of human subjects must comply with The University of 
Maine Policies and Procedures of the Institutional Review Board for the Protection of 
Human Subjects (IRB).  No research with human subjects shall be conducted until the 
Institutional Review Board for the Protection of Human Subjects (IRB) has approved the 
research protocol.  Responsibility for ensuring compliance with The University of Maine 
Human Subjects Review Policy rests with the student’s thesis advisor.  Evidence of IRB 




Student violations of the Human Subjects Review Policy will be handled on an individual 
basis in accordance with existing University of Maine or college/departmental policy.  
The inclusion in a thesis or dissertation of data involving human subjects which was 
obtained through procedures which did not receive prior approval by the IRB will 
ordinarily not be permitted. 
 
10.2.4  Animal Subjects Approval 
 
Graduate students performing research or testing using live vertebrate animals must 
obtain the approval of the Institutional Animal Care and Use Committee (IACUC) before 
initiating such studies.  Responsibility for ensuring compliance with The University of 
Maine Policies and Procedures for the Humane Care and Use of Animals rests with the 
student’s thesis advisor.  Evidence of IACUC approval, if applicable, must be noted on 
the student’s Final Thesis Acceptance Form.  Student violations of the Policies and 
Procedures for the Humane Care and Use of Animals will be handled on an individual 
basis in accordance with existing University of Maine or college/departmental policy.  
The inclusion in a thesis or dissertation of data involving animal subjects which was 
obtained through procedures which did not receive prior approval by the IACUC will 
ordinarily not be permitted.  
 
10.3  Form and Preparation of Thesis   
 
It is expected that each department will guide its own students in the selection of the 
appropriate manual to be used in order that students will have experience with accepted 
practice in their own fields.  The specific guidelines for thesis and dissertation 
preparation are available from the Graduate School’s website at umaine.edu/graduate. 
 




The original copy of the thesis shall be submitted electronically in PDF format to the 
Graduate School.  
 
The thesis must be standard, double-spaced throughout, except for quotations, footnotes, 
bibliographies, and illustrations, which may be single-spaced. Each page of the thesis 
shall have a margin of at least one inch on the left, right, top, and bottom.  The only 
matter which may be outside these imaginary margin lines is the page number.  With the 
exception of the Abstract which are not included in the pagination of the thesis, all pages 
are assigned page numbers.  Small Roman numerals are used for the preliminary pages 
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 Research with human subjects at the University of Maine shall be guided by three 
general ethical principles: respect for persons, beneficence, and justice. These 
principles and the rules that may be derived from them shall form the analytical 
framework for determining whether and how research with human subjects may 
be conducted. Researchers must respect and protect the rights and privacy and 
welfare of individuals recruited for and participating in research. More precisely, 
all human subject research must comply with the US Department of Health and 
Human Services (DHHS) “Common Rule” 45 CFR 46; 21 CFR 50; the Belmont 
Report; The Nuremburg Code; and the Declaration of Helsinki. 
 
The University shall maintain and support an Institutional Review Board for the 
Protection of Human Subjects (IRB), whose function it is to determine whether 
and how research with human subjects may be conducted, and to educate the 
community with regard to the protection of human subjects. 
 
No research with human subjects shall be conducted until the IRB has reviewed 
the research protocol. Before action is taken, proper consideration shall be given 
to the risks to the subjects, the anticipated benefits to the subjects and others, the 
importance of the knowledge that may reasonably be expected to result, and the 
informed consent process to be employed. 
 
The University of Maine shall acknowledge and accept responsibility for 
protecting the rights and welfare of human subjects of research. University 
Policies and Procedures for the Protection of Human Subjects of Research apply 
to all activities which include research with human subjects and: 
 
- are sponsored by the University; or 
 
- are conducted by or under the direction of any faculty, staff 
member, or student of the University in connection with his or her 
institutional responsibilities; or 
 
- are conducted by or under the direction of any faculty, staff 
member, or student of the University using any property or facility 
of the University; or 
 
 - involve the use of the University's nonpublic information. 
 
The University of Maine shall encourage and promote constructive 
communication among research administrators, department chairs, deans and 




officials as a means of maintaining a high level of awareness regarding the 
safeguarding of the rights and welfare of the subjects. 
 
 The University of Maine shall comply with all federal, state, and local regulations 
pertaining to the protection of human subjects. 
 
B. Student Class Projects 
 
1. Class projects that involve systematic collection of data and for which the 
design or objective is to develop or contribute to generalizable knowledge 
are considered research and require IRB review.  
 
2. Class projects that are designed: a) solely with the objective of providing 
students with training about and experience with research methods, and b) 
where data will not be used outside of the classroom context, and c) where 
data will be destroyed upon completion of the project, are not considered 
research and do not require IRB review. However, if the instructor allows 
a student to design a class project that involves protected populations or 
sensitive information, IRB review and approval are required. (See 
document, Guidelines for Class Projects for additional information.) 
 
C. Research Activities that May Be Exempt from Further Review 
 
Exempt - The Common Rule outlines certain types of research that are exempt 
from Institutional Review Board (IRB) oversight: 45 CFR 46.104(d); 21 CFR 50 
and 56 [US Food and Drug Administration (FDA research)]. Only the IRB can 
determine if a proposed project qualifies as exempt from further review. Principal 
Investigators (PI) whose research is judged exempt from further review are not 
required to have any further interaction with the IRB unless adverse events occur, 
or there is a substantial change to the protocol. 
 
 Exempt Categories: 
 
1. Research, conducted in established or commonly accepted educational 
settings, that specifically involves normal educational practices that are 
not likely to adversely impact students’ opportunity to learn required 
educational content or the assessment of educators who provide 
instruction. This includes most research on regular and special education 
instructional strategies, and research on the effectiveness of or the 
comparison among instructional techniques, curricula, or classroom 
management methods. 
 
2. Research that only includes interactions involving educational tests 
(cognitive, diagnostic, aptitude, achievement), survey procedures, 
interview procedures, or observation of public behavior (including visual 





(i) The information obtained is recorded by the investigator in such a 
manner that the identity of the human subjects cannot readily be 
ascertained, directly or through identifiers linked to the subjects;  
 
(ii) Any disclosure of the human subjects’ responses outside the 
research would not reasonably place the subjects at risk of criminal 
or civil liability or be damaging to the subjects’ financial standing, 
employability, educational advancement, or reputation; or 
 
(iii) The information obtained is recorded by the investigator in such a 
manner that the identity of the human subjects can readily 
ascertained, directly or through identifiers linked to the subjects, 
and an IRB conducts a limited IRB review to make the 
determination required by 46.111(a)(7).  
 
3.  (i) Research involving benign behavioral interventions in conjunction with the 
collection of information from an adult subject through verbal or written 
responses (including data entry) or audiovisual recording if the subject 
prospectively agrees to the intervention and information collection and at 
least one of the following criteria is met: 
 
 1) The information obtained is recorded by the investigator in such a 
manner that the identity of the human subjects cannot readily be 
ascertained, directly or through identifiers linked to the subjects; 
 
 2) Any disclosure of the human subjects’ responses outside the 
research would not reasonably place the subjects at risk of criminal or civil 
liability or be damaging to the subjects’ financial standing, employability, 
educational advancement, or reputation; or 
 
 3) The information obtained is recorded by the investigator in such a 
manner that the identity of the human subjects can readily be ascertained, 
directly or through identifiers linked to the subjects, and an IRB conducts 
a limited IRB review to make the determination required by 45.111(a)(7). 
 
   (ii) For the purpose of this provision, benign behavioral interventions are brief 
in duration, harmless, painless, not physically invasive, not likely to have 
a significant adverse lasting impact on the subjects, and the investigator 
has no reason to think the subjects will find the interventions offensive or 
embarrassing. Provided all such criteria are met, examples of such benign 
behavioral interventions would include having the subjects play an online 
game, having them solve puzzles under various noise conditions, or 
having them decide how to allocate a nominal amount of received cash 





(iii) If the research involves deceiving the subjects regarding the nature or  
purposes of the research, this exemption is not applicable unless the  
subject authorizes the deception through a prospective agreement to 
participate in research in circumstances in which the subject is informed 
that he or she will be unaware of or misled regarding the nature or  
purposes of the research. 
 
4. Secondary research for which consent is not required: Secondary research  
uses of identifiable private information or identifiable biospecimens, if at 
least one of the following criteria is met: 
(i) The identifiable private information or identifiable biospecimens are 
publicly available; 
(ii) Information, which may include information about biospecimens, is 
recorded by the investigator in such a manner that the identity of the 
human subjects cannot readily be ascertained directly or through 
identifiers linked to the subjects, the investigator does not contact the 
subjects, and the investigator will not re-identify subjects; 
(iii) The research involves only information collection and analysis 
involving the investigator's use of identifiable health information when 
that use is regulated under 45 CFR parts 160 and 164, subparts A and E, 
for the purposes of “health care operations” or “research” as those terms 
are defined at 45 CFR 164.501 or for “public health activities and 
purposes” as described under 45 CFR 164.512(b); or 
(iv) The research is conducted by, or on behalf of, a Federal department or 
agency using government-generated or government-collected information 
obtained for nonresearch activities, if the research generates identifiable 
private information that is or will be maintained on information 
technology that is subject to and in compliance with section 208(b) of the 
E-Government Act of 2002, 44 U.S.C. 3501 note, if all of the identifiable 
private information collected, used, or generated as part of the activity will 
be maintained in systems of records subject to the Privacy Act of 1974, 5 
U.S.C. 552a, and, if applicable, the information used in the research was 
collected subject to the Paperwork Reduction Act of 1995, 44 U.S.C. 3501 
et seq. 
5. Research and demonstration projects that are conducted or supported by a 
Federal department or agency, or otherwise subject to the approval of 
department or agency heads (or the approval of the heads of bureaus or 
other subordinate agencies that have been delegated authority to conduct 
the research and demonstration projects), and that are designed to study, 




programs, including procedures for obtaining benefits or services under 
those programs, possible changes in or alternatives to those programs or 
procedures, or possible changes in methods or levels of payment for 
benefits or services under those programs. Such projects include, but are 
not limited to, internal studies by Federal employees, and studies under 
contracts or consulting arrangements, cooperative agreements, or grants. 
Exempt projects also include waivers of otherwise mandatory 
requirements using authorities such as sections 1115 and 1115A of the 
Social Security Act, as amended. 
(i) Each Federal department or agency conducting or supporting the 
research and demonstration projects must establish, on a publicly 
accessible Federal Web site or in such other manner as the department or 
agency head may determine, a list of the research and demonstration 
projects that the Federal department or agency conducts or supports under 
this provision. The research or demonstration project must be published on 
this list prior to commencing the research involving human subjects. 
6.  Taste and food quality evaluation and consumer acceptance studies: 
(i) If wholesome foods without additives are consumed, or 
(ii) If a food is consumed that contains a food ingredient at or below the 
level and for a use found to be safe, or agricultural chemical or 
environmental contaminant at or below the level found to be safe, by the 
Food and Drug Administration or approved by the Environmental 
Protection Agency or the Food Safety and Inspection Service of the U.S. 
















Adverse Event, Serious: Any unfavorable and unintended sign (including an 
abnormal laboratory finding), symptom, or disease temporally associated with the 
use of a medical treatment or procedure that may or may not be considered related 
to the medical treatment or procedure. 
 
 Serious Adverse Events include those that: 
 - Are fatal or life threatening;  
 - Result in significant or persistent disability;  
 - Require or prolong hospitalization;  
 - Result in a congenital anomaly/birth defect; or 
 - Represent other significant hazards or potentially serious harm to research 
subjects or others, in the opinion of the investigators.  
 
Unexpected Serious Adverse Events are those that have not been described in the: 
- Package insert for a given drug or investigator's brochure (for FDA 
investigational agents); 
- Approved protocol; or 
- Informed consent document. [21 CFR 312.32(a)] 
 
Adverse Research Event: Adverse research events include a wide spectrum of 
events. Adverse events include, but are not limited to: 
 
 - Physical or psychological harm or injuries; 
 - Threats to privacy or safety;  
 - Unusual attrition of human subjects;  
 - Breaches of confidentiality or emotional harms such as the emotional 
distress that could be triggered by questions about traumatic life events or 
a subject's complaints about the experimental procedures or the conduct of 
the investigators. 
 
Certificate of Confidentiality: A discretionary document issued by the National 
Institutes of Health (NIH), which helps researchers protect the privacy of human 
research participants enrolled in biomedical, behavioral, clinical, and other forms 
of sensitive research. Certificates protect against compulsory legal demands, such 
as court orders and subpoenas, for identifying information or identifying 
characteristics of a research participant. Further information is available at 
http://grants1.nih.gov/grants/policy/coc/.  
 
Coercion: To bring about participation in research by force or threat, actual or 





Common Rule: The federal regulation that is the primary source of human 
subjects’ protections. This is the common reference for 45 CFR 46, 
PROTECTION OF HUMAN SUBJECTS.  
 
Generalizable Knowledge: Currently, US DHHS Office of Human Research 
Protection (OHRP) does not have a formal position on what does and does not 
constitute “generalizable knowledge” beyond the language of the Common Rule. 
The University of Maine adopts the following definition of generalizable 
knowledge: 
 
Generalizable knowledge is information which has the potential to be 
expanded from the isolated circumstances in which it is acquired to any 
broader context. 
 
Thus, a case study, designed to illuminate the course of a single individual’s 
experience generally will not be considered to be developing or contributing to 
generalizable knowledge. A series of case studies, intended to lead to 
improvements in the management of a particular circumstance or condition, 
generally will be considered generalizable knowledge. 
 
Human Subject: “A living individual(s) about whom an investigator (whether 
professional or student) conducting research: 
 
(i) Obtains information or biospecimens through intervention or interaction 
with the individual, and uses, studies, or analyzes the information or 
biospecimens; or 
(ii) Obtains, uses, studies, analyzes, or generates identifiable private 





Institutional Review Board (IRB): A research review committee whose primary 
purpose is to review all research involving human subjects and to provide 
oversight of human subjects’ protections.   
 
Interaction: A communication or interpersonal contact between investigator and 
subject for research purposes. 
 
Intervention: Includes both physical procedures by which information or 
biospecimens are gathered (e.g., venipuncture) and manipulations of the subject 
or the subject's environment that are performed for research purposes. 
 
Key Research Personnel: Persons who have direct contact with subjects, 




identifiable data or biological samples (e.g., tissue, blood, urine, plasma, saliva), 
or use subjects’ personal information. 
 
Minimal Risk: “The probability and magnitude of harm or discomfort anticipated 
in the research are not greater in and of themselves than those ordinarily 
encountered in daily living or during the performance of routine physical or 
psychological examinations or tests.” [45 CFR 46.102(i)] 
 
Minor: An individual under the age of 18 years. 
 
Minor Changes: Minor changes have no substantive effect upon an approved 
protocol or reduce the protocol risk already approved by the IRB. Examples of 
minor changes are:  
 
- Changes in research personnel that do not alter the competence of the 
research team to conduct the research, or 
- Minimal changes in remuneration. 
 
Principal Investigator (PI): Any University of Maine faculty, staff member, or 
student so designated in a protocol who is the primary person responsible for all 
aspects of the research project and assumes all responsibilities for the results.  
 
Prisoner: Any individual, regardless of age, involuntarily confined or detained in 
a penal institution or a parolee detained in a treatment center as a condition of 
parole. The term is intended to encompass individuals sentenced to such an 
institution under a criminal or civil statute, individuals detained in other facilities 
by virtue of statutes or commitment procedures that provide alternatives to 
criminal prosecution or incarceration in a penal institution, and individuals 
detained pending arraignment, trial, or sentencing. This definition also includes 
data from non-publicly available databases and secondary sources. The University 
of Maine extends the term “prisoner” to include persons on pre-trial supervised 
release, on community supervision or on probation, or who is in any court-ordered 
deferred prosecution or diversion program. 
 
Private Information: includes information about behavior that occurs in a 
context in which an individual can reasonably expect that no observation or 
recording is taking place, and information that has been provided for specific 
purposes by an individual and that the individual can reasonably expect will not 
be made public (e.g., a medical record). 
Identifiable private information is private information for which the identity of 
the subject is or may readily be ascertained by the investigator or associated 




An identifiable biospecimen is a biospecimen for which the identity of the 
subject is or may readily be ascertained by the investigator or associated with 
the biospecimen. 
 
Protected Population: (Also referred to as protected subject group). These 
groups of potential research subjects have specific regulatory compliance 
requirements and receive special protections under the Common Rule and/or other 
federal regulations. These groups include (but not restricted to): 
 
 - Children/Minors (under the age of 18)  
 - Prisoners (now includes non-publicly available secondary data) 
 - Pregnant women 
 - Fetuses and products of labor and delivery 
 - People with diminished capacity to give consent  
 - Mentally or physically challenged individuals 
 
Protocol: Any type of research project that is submitted for IRB review (also 
known as a research project, proposal, submission, etc.). 
 
Protocol Violation, Major: A major protocol violation occurs when there is a 
variance in a research study between the protocol that has been reviewed and 
approved by the IRB and the actual activities being performed. Major protocol 
violations include violations that:  
 
- Cause or pose a significant risk of substantive harm to research 
participants; 
- Damage the scientific integrity of the data collected;  
- Show evidence of willful or knowing misconduct on the part of the 
investigator; or  
- Demonstrate a serious or continued noncompliance with federal, state or 
local research policy, laws, or regulations.  
 
Protocol Violation, Minor: A minor protocol violation occurs when there is a 
variance in a research study between the protocol that has been reviewed and 
approved by the IRB and the actual activities being performed. Minor protocol 
violations include violations that: 
 
 - Have no substantive effect on the risks to research participants;  
- Do not impact the value of the data collected (meaning the violation does 
not confound the scientific analysis of the results); and  
- Do not result from willful or knowing misconduct on the part of the 
investigator(s). 
 
Research: The University of Maine takes as its starting point the federal 





Research means a systematic investigation, including research 
development, testing and evaluation, designed to develop or 
contribute to generalizable knowledge. Activities that meet this 
definition constitute research for purposes of this policy, whether 
or not they are conducted or supported under a program that is 
considered research for other purposes. For example, some 
demonstration and service programs may include research 
activities). Please note that risk assessment plays no role in the 
determination of whether a proposed activity constitutes 
research. See also the definition of generalizable knowledge, 
above. 
For purposes of this part, the following activities are deemed not to 
be research:  
 
(1) Scholarly and journalistic activities (e.g., oral history, journalism, 
biography, literary criticism, legal research, and historical scholarship), including 
the collection and use of information, that focus directly on the specific 
individuals about whom the information is collected. 
(2) Public health surveillance activities, including the collection and 
testing of information or biospecimens, conducted, supported, requested, ordered, 
required, or authorized by a public health authority. Such activities are limited to 
those necessary to allow a public health authority to identify, monitor, assess, or 
investigate potential public health signals, onsets of disease outbreaks, or 
conditions of public health importance (including trends, signals, risk factors, 
patterns in diseases, or increases in injuries from using consumer products). Such 
activities include those associated with providing timely situational awareness and 
priority setting during the course of an event or crisis that threatens public health 
(including natural or man-made disasters). 
(3) Collection and analysis of information, biospecimens, or records by or 
for a criminal justice agency for activities authorized by law or court order solely 
for criminal justice or criminal investigative purposes. 
(4) Authorized operational activities (as determined by each agency) in 




Research Misconduct (42 CFR §93.103): means fabrication, falsification, or 
plagiarism in proposing, performing, or reviewing research, or in reporting 




- Fabrication is making up data or results and recording or reporting them as 
if they were real. 
- Falsification is manipulating research materials, equipment, or processes, 
or changing or omitting data or results such that the research is not 
accurately represented in the research record. 
- Plagiarism is the appropriation of another person's ideas, processes, 
results, or words without giving appropriate credit. 
- Research misconduct does not include honest error or differences of 
opinion. 
  
Sensitive Information: According to the NIH Certificate of Confidentiality 
Kiosk, sensitive information is that which, if disclosed, may reasonably pose a 
risk to the subject’s psychological, social, medical, legal, or economic well-being 
or quality of life. Categories of sensitive information include (but are not limited 
to): 
 
- Sexual attitudes, preferences, or practices 
- Use of alcohol, drugs, or other addictive products 
- Information pertaining to illegal conduct 
- Information that if released might be damaging to an individual’s financial 
standing, employability, or reputation within the community or might lead 
to social stigmatization or discrimination 
- Health and medical information contained in a medical record, chart, or 
insurance file (this category may also require a HIPAA review)  
- Information pertaining to an individual's psychological well-being or 
mental health (this category may also require a HIPAA review) 
- Genetic information or tissue samples (this category may also require a 
HIPAA review) 
 
Signatory/Institutional Official: The signatory/institutional official (IO) is the 
highest institutional official who has the legal authority to represent the 
University of Maine’s Assurance filed with the OHRP, and is responsible for the 
provisions of this policy. At the University of Maine, the signatory/institutional 
official is the Vice President for Research. 
 
Specimen: Specimen is used to refer to biological specimens (e.g., blood or tissue 
samples), as well as to other types of data "specimens" that could be stored for use 
in future research (e.g., audio tapes, video tapes, etc.). 
Substantive Changes Affecting Risk: Substantive changes are changes that may 
increase the research population's risk or are of questionable risk. Examples of 
substantive changes that are considered to increase the risk to the study/individual 
include, but are not limited to:  
- Increasing the length of time a study participant is exposed to 




- Changing the originally targeted population to include a more at-risk 
population (e.g., previous exclusion for those with renal failure are now 
allowed to enroll, or adding children or pregnant women to the study).  
- Adding an element that may breach the confidentiality of the subject such 
as tissue banking or genetic testing.  
 
Undue Influence: Inappropriate remuneration or any other form of compulsion 
offered to an individual that may unfairly compel that individual to participate as 
a human research subject. 
 
Unanticipated Problem: Any event that is not expected given the nature of the 
research procedures and the subject population being studied, and places subjects 
or others at greater risk or harm/discomfort related to the research than was 
previously known or recognized. An event which was previously unforeseeable 
based on the information provided to the IRB. 
 
Written or in writing: refers to writing on a tangible medium (e.g., paper) or in 
an electronic format.  
 
E. Responsibilities of the Principal Investigator 
 
 The individual faculty, staff member, or student of the University who conducts 
or directs research with human subjects exercises the following responsibilities: 
 
1. The Principal Investigator shall submit an application for Approval of 
Research with Human Subjects to the Board. The application includes all 
criteria for submission.  
 
2. The Principal Investigator and personnel named in the application or who 
will have access to data, shall complete the required training. 
 
3. The Principal Investigator shall begin the research project ONLY after 
receiving written approval from the IRB. 
 
4. The Principal Investigator shall make no alterations to the approved 
protocol without the prior approval of such alterations by the IRB. 
 
5. The Principal Investigator shall report at once to the IRB any 
unanticipated harm to human subjects. 
 
6. The Principal Investigator shall submit a status report to the IRB on the 
conduct of the research and shall seek approval for continuation of the 
research at least annually, and more frequently if the IRB so requires.  
 
7. The Principal Investigator shall cooperate fully with the Protection of 





F. IRB Membership 
 
The IRB is responsible not only for reviewing, regulating, and monitoring human 
subject research but also for educating the University community in the protection 
of human subjects. 
 
1. The IRB shall have no fewer than five voting members, with varying 
backgrounds to promote complete and adequate review of research 
activities commonly conducted by the institution. The IRB shall be 
sufficiently qualified through the experience and expertise of its members, 
and the diversity of the members, including consideration of race, gender, 
and cultural backgrounds and sensitivity to such issues as community 
attitudes, to promote respect for its advice and counsel in safeguarding the 
rights and welfare of human subjects. 
 
2. A list of IRB members identified by name; earned degrees; representative 
capacity; indications of experience such as board certifications, licenses, 
etc., sufficient to describe each member’s chief anticipated contributions 
to IRB deliberations; and any employment or other relationship between 
each member and the institution, e.g., full-time employee, part-time 
employee, member of governing panel or board, stockholder, paid or 
unpaid consultant. Changes in IRB membership shall be reported to US 
DHHS’s OHRP. 
 
3. The IRB shall include at least one member whose primary concerns are in 
scientific areas and at least one member whose primary concerns are in 
nonscientific areas. The IRB shall include at least one member who is not 
otherwise affiliated with the institution and who is not part of the 
immediate family of a person who is affiliated with the institution. At least 
one member’s area of expertise shall include children. At least one 
member shall be a prisoner, or a prisoner representative with appropriate 
background and experience to serve in that capacity. The IRB may NOT 
have a member participate in the initial or continuing review of any 
project in which the member has a conflicting interest, except to provide 
information requested by the IRB. The IRB may invite individuals with 
competence in special areas to assist in the review of issues that require 
expertise beyond or in addition to that available to the IRB; such 
individuals may not vote with the IRB. 
 
4. Members are appointed for one to three-year terms and may be 
reappointed to additional terms.  
 
5. All IRB members are formally confirmed by the President (or designee) of 





6. The Chair of the IRB should be a tenured faculty member with experience 
in conducting human subject research. Appointment is confirmed 
officially by the President or designee and is for two years; may be 
reappointed to additional terms. A Vice Chair may be appointed, if 
desired, using the same confirmation procedure. 
 
G. IRB Functions and Operations 
 
 The IRB shall: 
1. Follow written procedures in the same detail as described in 45 CFR 
46.103(b)(4), and to the extent required by 45 CFR 46.103(b)(5). 
2. Except when an expedited review procedure is used (see section I.), 
review proposed research at convened meetings at which a majority of the 
members of the IRB are present, including at least one member whose 
primary concerns are in nonscientific areas. In order for the research to be 
approved, it shall receive the approval of a majority of those members 
present at the meeting 
H. IRB Review of Research 
 
1. All research shall be reviewed by the IRB. The IRB shall make the final 
decision on whether research is exempt from further review or meets the 
requirements for an expedited review. The IRB shall review protocol 
applications and has the authority to approve, require modifications, or 
disapprove research activities with human subjects. 
 
2. Ensures that legally effective informed consent of human research subjects 
will be obtained in a manner and method that meets the requirements of 
federal, state, and local rules and laws and in accordance with section K. 
 
3. The IRB shall require documentation of informed consent or may waive 
documentation in accordance with section L. 
 
4. The IRB shall notify investigators and the Institutional Official in writing 
of its decision to approve or disapprove the proposed research activity, or 
of modifications required to secure IRB approval of the research activity. 
If the IRB decides to disapprove a research activity, it shall include in its 
written notification a statement of the reasons for its decision and give the 
investigator an opportunity to respond in person or in writing. 
 
5. The IRB shall monitor the research it has approved by any means it deems 
appropriate, including observation of the consent process and the research 





6. The IRB shall conduct continuing review of approved research activities at 
intervals appropriate to the degree of risk, but not less than once per year, 
except as described in 7 below 
 
 
7. Unless an IRB determines otherwise, continuing review of research is not 
required in the following circumstances: 
 
i) Research eligible for expedited review in accordance with 46.110. 
ii) Research reviewed by the IRB in accordance with the limited IRB 
review described in 46.111 
iii) Research that has progressed to the point that it involves only one 
or both of the following, which are part of the IRB-approved study: 
 
(a) Data analysis, including analysis of identifiable private 
information or identifiable biospecimens, or 
(b) Accessing follow-up clinical data from procedures that subjects 
would undergo as part of clinical care 
 
8. An IRB shall have authority to observe or have a third party observe the 
consent process and the research.  
 
I. Expedited Review Procedures  
 
1. Following is a list of categories of research that may be reviewed by the 
IRB through an expedited review procedure. Investigators may request an 
expedited review when proposed research activities meet one or more of 
these categories. Ten business days are required for an expedited review. 
(Note: projects falling into one of the exemption categories – section C. --




a. Research activities that (i) present no more than minimal risk to 
human subjects, and (ii) involve only procedures listed in one or 
more of the categories detailed below, may be reviewed by the IRB 
through the expedited review procedure authorized by 45 CFR 
46.110 and 21 CFR 56.110. The activities listed should not be 
deemed to be of minimal risk simply because they are included on 
this list. Inclusion on this list merely means that the activity is 
eligible for review through the expedited review procedure when 
the specific circumstances of the proposed research involve no 
more than minimal risk to human subjects. 
 
b. The categories in this list apply regardless of the age of subjects, 





c. The expedited review procedure may not be used where 
identification of the subjects and/or their responses would 
reasonably place them at risk of criminal or civil liability or be 
damaging to the subjects’ financial standing, employability, 
insurability, reputation, or be stigmatizing, unless reasonable and 
appropriate protections will be implemented so that risks related to 
invasion of privacy and breach of confidentiality are no greater 
than minimal. 
 
d. The expedited review procedure may not be used for classified 
research involving human subjects. 
 
e. IRBs are reminded that the standard requirements for informed 
consent (or its waiver, alteration, or exception) apply regardless of 
the type of review--expedited or convened--utilized by the IRB. 
 
f. Research categories 3.a. through 3.g. below pertain to both initial 
and continuing IRB review. 
 
  3. Research Categories 
 
a. Clinical studies of drugs and medical devices only when condition 
1) or 2) is met. 
 
1) Research on drugs for which an investigational new drug 
application (21 CFR part 312) is not required. (Note: 
research on marketed drugs that significantly increases the 
risks or decreases the acceptability of the risks associated 
with the use of the product is not eligible for expedited 
review.) 
 
2) Research on medical devices for which (i) an 
investigational device exemption application (21 CFR part 
812) is not required; or (ii) the medical device is 
cleared/approved for marketing, and the medical device is 
being used in accordance with its cleared/approved 
labeling. 
 
b. Collection of blood samples by finger stick, heel stick, ear stick, or 
venipuncture as follows: 
 
1) from healthy, nonpregnant adults who weigh at least 110 
pounds. For these subjects, the amounts drawn may not 
exceed 550 ml in an 8-week period and collection may not 





2) from other adults and children, considering the age, weight, 
and health of the subjects, the collection procedure, the 
amount of blood to be collected, and the frequency with 
which it will be collected. For these subjects, the amount 
drawn may not exceed the lesser of 50 ml or 3 ml per kg in 
an 8-week period and collection may not occur more 
frequently than 2 times per week. 
 
c. Prospective collection of biological specimens for research 
purposes by noninvasive means. 
 
 Examples: (a) hair and nail clippings in a nondisfiguring manner; 
(b) deciduous teeth at time of exfoliation or if routine patient care 
indicates a need for extraction; (c) permanent teeth if routine 
patient care indicates a need for extraction; (d) excreta and external 
secretions (including sweat); (e) uncannulated saliva collected 
either in an unstimulated fashion or stimulated by chewing 
gumbase or wax or by applying a dilute citric solution to the 
tongue; (f) placenta removed at delivery; (g) amniotic fluid 
obtained at the time of rupture of the membrane prior to or during 
labor; (h) supra- and subgingival dental plaque and calculus, 
provided the collection procedure is not more invasive than routine 
prophylactic scaling of the teeth and the process is accomplished in 
accordance with accepted prophylactic techniques; (i) mucosal and 
skin cells collected by buccal scraping or swab, skin swab, or 
mouth washings; (j) sputum collected after saline mist 
nebulization. 
 
d. Collection of data through noninvasive procedures (not involving 
general anesthesia or sedation) routinely employed in clinical 
practice, excluding procedures involving x-rays or microwaves. 
Where medical devices are employed, they must be 
cleared/approved for marketing. Studies intended to evaluate the 
safety and effectiveness of the medical device are not generally 
eligible for expedited review, including studies of cleared medical 
devices for new indications. 
 Examples: (a) physical sensors that are applied either to the surface 
of the body or at a distance and do not involve input of significant 
amounts of energy into the subject or an invasion of the subject’s 
privacy; (b) weighing or testing sensory acuity; (c) magnetic 
resonance imaging; (d) electrocardiography, 
electroencephalography, thermography, detection of naturally 
occurring radioactivity, electroretinography, ultrasound, diagnostic 
infrared imaging, doppler blood flow, and echocardiography; (e) 




assessment, and flexibility testing where appropriate given the age, 
weight, and health of the individual. 
 
e. Research involving materials (data, documents, records, or 
specimens) that have been collected, or will be collected solely for 
nonresearch purposes (such as medical treatment or diagnosis). 
(NOTE: Some research in this category may be exempt from the 
DHHS regulations for the protection of human subjects. [45 CFR 
46.101(b)(4)]. This listing refers only to research that is not 
exempt.) 
 
f. Collection of data from voice, video, digital, or image recordings 
made for research purposes. 
 
g. Research on individual or group characteristics or behavior 
(including, but not limited to, research on perception, cognition, 
motivation, identity, language, communication, cultural beliefs or 
practices, and social behavior) or research employing survey, 
interview, oral history, focus group, program evaluation, human 
factors evaluation, or quality assurance methodologies. (NOTE: 
Some research in this category may be exempt from the DHHS 
regulations for the protection of human subjects. [45 CFR 
46.101(b)(2) and (b)(3)]. This listing refers only to research that is 
not exempt.) 
 
h. Continuing review of research previously approved by the 
convened IRB as follows: 
 
1) where(i) the research is permanently closed to the 
enrollment of new subjects; (ii) all subjects have completed 
all research-related interventions; and (iii) the research 
remains active only for long-term follow-up of subjects; or  
 
2) where no subjects have been enrolled and no additional 
risks have been identified; or 
 
3) where the remaining research activities are limited to data 
analysis. 
 
i. Continuing review of research, not conducted under an 
investigational new drug application or investigational device 
exemption where research categories 3.b. through 3.h. do not 
apply, but the IRB has determined and documented at a convened 
meeting that the research involves no greater than minimal risk and 





4. The IRB may use the expedited review procedure to review either or both 
of the following: 
 
a. some or all of the research appearing on the list and found by the 
reviewer(s) to involve no more than minimal risk; 
 
b. minor changes in previously approved research during the period 
(of one year or less) for which approval is authorized. 
 
 Under an expedited review procedure, the review may be carried out by 
the IRB chairperson or by one or more experienced reviewers designated 
by the chairperson from among members of the IRB. In reviewing the 
research, the reviewers may exercise all of the authorities of the IRB 
except that the reviewers may not disapprove the research. A research 
activity may be disapproved only after review in accordance with the non-
expedited procedure set forth in §46.108(b). 
 
5. The IRB shall keep all members advised of research proposals that have 
been approved under the expedited review procedure by including a list of 
those proposals on the monthly agenda and subsequent minutes. 
 
6. The department or agency heads1 may restrict, suspend, terminate, or 
choose not to authorize an institution's or IRB's use of the expedited 
review procedure. 
 
J. Criteria for IRB Approval of Research 
 
 The IRB approves research only when it has determined that all of the following 
requirements are satisfied: 
 
1. Risks to subjects are minimized. Procedures used are consistent with 
sound research design and do not unnecessarily expose subjects to risk. 
Whenever appropriate, the research uses procedures already being 
performed on the subjects for other purposes, such as diagnosis or 
treatment. 
 
2. Risks to subjects are reasonable in relation to anticipated benefits, if any, 
to the subjects, and the importance of the knowledge that may reasonably 
be expected to result. The IRB considers only those risks and benefits that 
may result from the research. The IRB does not consider possible long-
range effects of applying knowledge gained in the research as among 
those research risks that fall within the purview of its responsibility. 
 
                                                 
1 “Department or Agency heads” refers specifically to the heads of various federal 




3. The selection of subjects is equitable, taking into account the purpose of 
the research and the setting in which the research will be conducted. 
 
4. Informed consent is sought from each prospective subject or the subject’s 
legally authorized representative. The IRB conforms to federal regulations 
of informed consent procedures and may impose additional requirements. 
 
5. Informed consent is appropriately documented or appropriately waived, in 
accordance with, and to the extent required by, federal regulations. The 
IRB may also impose documentation requirements in addition to those 
required by federal regulations. 
 
6. When appropriate, the research protocol makes adequate provision for 
monitoring the data collected to insure the safety of subjects. 
 
7. When appropriate, there are adequate provisions to protect the privacy of 
subjects and to maintain the confidentiality of data.  
 
8. When some or all of the subjects are likely to be vulnerable to coercion or 
undue influence, appropriate additional safeguards have been included in 
the protocol to protect the rights and welfare of these subjects. 
 
K. General Requirements for Informed Consent 
 
 Except as provided elsewhere in this policy, no investigator may involve a human 
being as a subject in research covered by this policy unless the investigator has 
obtained the legally effective informed consent of the subject or the subject's 
legally authorized representative. An investigator shall seek such consent only 
under circumstances that provide the prospective subject or the representative 
sufficient opportunity to consider whether or not to participate and that minimize 
the possibility of coercion or undue influence. The information that is given to the 
subject or the representative shall be in language understandable to the subject or 
the representative. No informed consent, whether oral or written, may include any 
exculpatory language through which the subject or the representative is made to 
waive or appear to waive any of the subject's legal rights, or releases or appears to 
release the investigator, the sponsor, the institution or its agents from liability for 
negligence. 
 
1. Basic elements of informed consent. Except as provided in paragraph 3. or 
4. of this section, in seeking informed consent the following information 
shall be provided to each subject: 
 
a. A statement that the study involves research, an explanation of the 
purposes of the research and the expected duration of the subject's 
participation, a description of the procedures to be followed, and 





b. A description of any reasonably foreseeable risks or discomforts to 
the subject; 
 
c. A description of any benefits to the subject or to others which may 
reasonably be expected from the research; 
 
d. A disclosure of appropriate alternative procedures or courses of 
treatment, if any, that might be advantageous to the subject; 
 
e. A statement describing the extent, if any, to which confidentiality 
of records identifying the subject will be maintained; 
 
f. For research involving more than minimal risk, an explanation as 
to whether any compensation and an explanation as to whether any 
medical treatments are available if injury occurs and, if so, what 
they consist of, or where further information may be obtained; 
 
g. An explanation of whom to contact for answers to pertinent 
questions about the research and research subjects' rights, and 
whom to contact in the event of a research-related injury to the 
subject; and 
 
h. A statement that participation is voluntary; refusal to participate 
will involve no penalty or loss of benefits to which the subject is 
otherwise entitled, and the subject may discontinue participation at 
any time without penalty or loss of benefits to which the subject is 
otherwise entitled. 
  
2. Additional elements of informed consent. When appropriate, one or more 
of the following elements of information shall also be provided to each 
subject: 
 
a. A statement that the particular treatment or procedure may involve 
risks to the subject (or to the embryo or fetus, if the subject is or 
may become pregnant) that are currently unforeseeable; 
 
b. Anticipated circumstances under which the subject's participation 
may be terminated by the investigator without regard to the 
subject's consent; 
 
c. Any additional costs to the subject that may result from 





d. The consequences of a subject's decision to withdraw from the 
research and procedures for orderly termination of participation by 
the subject; 
 
e. A statement that significant new findings developed during the 
course of the research that may relate to the subject's willingness to 
continue participation will be provided to the subject; and 
 
  f. The approximate number of subjects involved in the study. 
 
3. The IRB may approve a consent procedure that does not include, or which 
alters, some or all of the elements of informed consent set forth above, or 
waive the requirement to obtain informed consent provided the IRB finds 
and documents that: 
 
a. The research or demonstration project is to be conducted by or 
subject to the approval of state or local government officials and is 
designed to study, evaluate, or otherwise examine: (i) public 
benefit or service programs; (ii) procedures for obtaining benefits 
or services under those programs; (iii) possible changes in or 
alternatives to those programs or procedures; or (iv) possible 
changes in methods or levels of payment for benefits or services 
under those programs; and 
 
b. The research could not practicably be carried out without the 
waiver or alteration. 
 
4. The IRB may approve a consent procedure which does not include, or 
which alters, some or all of the elements of informed consent set forth in 
this section, or waive the requirements to obtain informed consent 
provided the IRB finds and documents that: 
 
a. The research involves no more than minimal risk to the subjects; 
and 
 
b. The waiver or alteration will not adversely affect the rights and 
welfare of the subjects; and 
 
c. The research could not practicably be carried out without the 
waiver or alteration; and 
 
d. Whenever appropriate, the subjects will be provided with 
additional pertinent information after participation. 
 
5. The informed consent requirements in this policy are not intended to 




information to be disclosed in order for informed consent to be legally 
effective. 
 
6. Nothing in this policy is intended to limit the authority of a physician to 
provide emergency medical care, to the extent the physician is permitted 
to do so under applicable federal, state, or local law. 
 
L. Documentation of Informed Consent 
 
1. Except as provided in paragraph 3. of this section, informed consent shall 
be documented by the use of a written consent form approved by the IRB 
and signed by the subject or the subject’s legally authorized 
representative. A copy shall be given to the person signing the form. 
 
2. Except as provided in paragraph 3. of this section, the consent form may 
be either of the following: 
 
a. A written consent document that embodies the elements of 
informed consent required by section K. This form may be read to 
the subject or the subject’s legally authorized representative, but in 
any event, the investigator shall give either the subject or the 
representative adequate opportunity to read it before it is signed; or 
 
b. A short written consent document stating that the elements of 
informed consent required by section K. have been presented 
orally to the subject or the subject’s legally authorized 
representative. When this method is used, there shall be a witness 
to the oral presentation. Also, the IRB shall approve a written 
summary of what is to be said to the subject or the representative. 
Only the short form itself is to be signed by the subject or the 
representative. However, the witness shall sign both the short form 
and a copy of the summary, and the person actually obtaining 
consent shall sign a copy of the summary. A copy of the summary 
shall be given to the subject or the representative, in addition to a 
copy of the short form. 
 
3. The IRB may waive the requirement for the investigator to obtain a signed 
consent form for some or all subjects if it finds either: 
 
a. That the only record linking the subject and the research would be 
the consent document, and the principal risk would be potential 
harm resulting from a  breach of confidentiality. Each subject will 
be asked whether the subject wants documentation linking the 





b. That the research presents no more than minimal risk of harm to 
subjects and involves no procedures for which written consent is 
normally required outside of the research context. 
 
 In cases in which the documentation requirement is waived, the IRB may 
require the investigator to provide subjects with a written statement 
regarding the research. 
 
M. Assurance of Compliance 
 
 The University of Maine conducts federally funded non-exempt human subject 
research; as such, it has a legally binding agreement with US DHHS -- a Federal 
Wide Assurance. This Federal Wide Assurance is administered by US DHHS’s 
OHRP and governs all human subject research receiving, or eligible to receive 
federal (US DHHS) funds. This agreement is guided by the ethical principles of 
the Belmont Report and requires, at a minimum, compliance with 45 CFR 46 (The 
Common Rule). The University of Maine’s Federal Wide Assurance number is: 
FWA00000479. 
 
N. Review by Institution 
 
 Research covered by this policy that has been approved by the IRB may be 
subject to further appropriate review and approval or disapproval by officials of 
the institution. However, those officials may not approve the research if it has not 
been approved by the IRB.  
  
O. Suspension or Termination of IRB Approval of Research 
 
 The IRB has authority to suspend or terminate approval of research that is not 
being conducted in accordance with the IRB’s requirements or that has been 
associated with unexpected serious harm to subjects. When the IRB exercises this 
authority, it promptly communicates its action and the reasons for the action in 
writing to the Principal Investigator, Institutional Official or other appropriate 
campus official, and the extramural sponsor of the research, if any. 
 
P. Cooperative Research 
 
 Cooperative research projects are those projects covered by this policy, or the 
Common Rule, involving more than one institution, whether within UMaine 
System campuses or other institutions outside the System. In the conduct of 
cooperative research projects, each institution is responsible for safeguarding the 
rights and welfare of human subjects and for complying with this policy. A 
campus participating in a cooperative project may enter into a joint review 
arrangement with another campus IRB, rely upon the review of another qualified 





Q. IRB Records 
 
1. The IRB shall prepare and maintain adequate documentation of its 
activities, including the following: 
 
a. Copies of all research proposals reviewed, scientific evaluations, if 
any, that accompany the proposals, approved sample consent 
documents, progress reports submitted by investigators, and 
reports of injuries to subjects. 
 
b. Minutes of IRB meetings shall be in sufficient detail to show 
attendance at the meetings; actions taken by the IRB; votes on 
actions including the number of members voting for, against, and 
abstaining; basis for requiring changes in or disapproving research; 
and a written summary of the discussion of controverted issues and 
their resolution. 
 
c. Records of continuing review activities. 
 
  d. Copies of all correspondence between the IRB and the investigator. 
 
e. A list of all IRB members in the same detail as described in section 
F. 
 
f. Written procedures for the IRB in the same detail as described in 
§46.103(b)(4) and §46.103(b)(5). 
 
g. Statements of significant new findings provided to subjects, as 
required by §46.103(b)(5). 
 
2. The records required by this policy shall be retained for at least 3 years; 
and records relating to research that is conducted shall be retained for at 
least 3 years after completion of the research. All records shall be 
accessible for inspections and copying by authorized representatives of US 
DHHS OHRP at reasonable times and in a reasonable manner. 
 
R. Applications and Proposals Lacking Definite Plans for Involvement of 
Human Subjects 
 
 Certain types of research proposals may not have fully defined plans set forth in 
the application or proposal. Such proposals may include institutional type grants 
when selection of specific projects is the institution's responsibility; research 
training grants in which the activities involving subjects remain to be selected; 
and projects in which human subjects' involvement will depend upon completion 
of instruments, prior animal studies, or purification of compounds. These 




be filed, nor before an award may be made. However, no human subjects may be 
involved in any project supported by these awards until the project has been 
reviewed and approved by the IRB. 
 
S. Research Undertaken without the Intention of Involving Human Subjects 
 
 In the event research is undertaken without the intention of involving human 
subjects, but it is later proposed to involve human subjects in the research, the 
research shall first be reviewed and approved by the IRB. 
 
T. Use of Federal Funds 
 
 Federal funds administered by a department or agency may not be expended for 
research involving human subjects unless the requirements of this policy have 
been satisfied. 
 
U. Early Termination of Research Support: Evaluation of Applications  
and Proposals 
 
1. The IRB, senior administrator responsible for the IRB, or the UMaine 
System may terminate or suspend an approved project if an investigator 
has failed to comply with the terms of this policy. 
 
2. The IRB, senior administrator responsible for the IRB, or the UMaine 
System may take into account, in addition to all other eligibility 
requirements and program criteria, factors such as whether the applicant 
has been subject to a termination or suspension under paragraph 1. of this 
section and whether the applicant or the person or persons who would 
direct or has/have directed the scientific and technical aspects of an 
activity has/have in their judgment materially failed to discharge 
responsibility for the protection of the rights and welfare of human 




 With respect to any research project or any class of research projects, the senior 
administrator responsible for the IRB or the UMaine System may impose 





II. Research Involving Children 
 
A.  Applicability 
 
1. The regulations in this section are applicable to all biomedical and 
behavioral research involving children conducted by any member of the 
University of Maine. 
 
2. All research involving children as subjects must comply with any state or 
local laws limiting such research. 
 
3. The requirements of this section are in addition to those imposed under the 
other sections of the University of Maine Policies and Procedures for the 
Protection of Human Subjects of Research. 
 
4. Note that the exemptions described in section C. of Administrative 
Procedures for Human Subjects Research and at 45 CFR 46.101(b)(1) and 
(b)(3) through (b)(6) are applicable to this section. The exemption at 
§46.101(b)(2) regarding educational tests is also applicable to this section. 
However, the exemption at §46.101(b)(2) for research involving survey or 
interview procedures or observations of public behavior does not apply to 
research covered by this section, except for research involving observation 
of public behavior when the investigator(s) do not participate in the 




 As used in this section: 
 
1. Children are persons who have not attained the legal age for consent to 
treatments or procedures involved in the research, under the applicable 
law of the jurisdiction in which the research will be conducted. 
 
2. Assent means a child's affirmative agreement to participate in research. 
Mere failure to object should not, absent affirmative agreement, be 
construed as assent. 
 
3. Permission means the agreement of parent(s) or guardian to the 
participation of their child or ward in research. 
 
 4. Parent means a child's biological or adoptive parent. 
 
5. Guardian means an individual who is authorized under applicable state or 





C. Special IRB Duties 
 
 In addition to other responsibilities assigned to the IRB in this section, the IRB 
shall review research covered by this section and approve only research that 
satisfies the conditions of all applicable parts of this section. 
 
D. Research not Involving Greater than Minimal Risk (45 CFR 46.404) 
 
 Research in which the IRB finds no greater than minimal risk to children to be 
present may be approved only if the IRB finds that adequate provisions are made 
for soliciting the assent of the children and the permission of their parents or 
guardians, as set forth below. 
 
E. Research Involving Greater than Minimal Risk but Presenting the Prospect 
of Direct Benefit to the Individual Subject (45 CFR 46.405) 
 
 If the IRB finds that more than minimal risk to children is presented by an 
intervention or procedure that holds out the prospect of direct benefit for the 
individual subject, or by a monitoring procedure that is likely to contribute to the 
subject's well-being, the proposed research may be approved only if the IRB finds 
that: 
 
 1. The risk is justified by the anticipated benefit to the subjects; 
 
2. The relation of the anticipated benefit to the risk is at least as favorable to 
the subjects as that presented by available alternative approaches; and 
 
3. Adequate provisions are made for soliciting the assent of the children and 
permission of their parents or guardians as set forth in H. in this section. 
[§46.408] 
 
F. Research Involving Greater than Minimal Risk and no Prospect of Direct 
Benefit to the Individual Subject, but likely to Yield Generalizable 
Knowledge about the Subject’s Disorder or Condition (45 CFR 46.406) 
 
 If the IRB finds that more than minimal risk to children is presented by an 
intervention or procedure that does not hold out the prospect of direct benefit for 
the individual subject, or by a monitoring procedure that is not likely to contribute 
to the well-being of the subject, the proposed research may be approved only if 
the IRB finds that: 
 
 1. The risk represents a minor increase over minimal risk; 
 
2. The intervention or procedure presents experiences to subjects that are 
reasonably commensurate with those inherent in their actual or expected 





3. The intervention or procedure is likely to yield generalizable knowledge 
about the subjects' disorder or condition that is of vital importance for the 
understanding or amelioration of the subjects' disorder or condition; and 
 
4. Adequate provisions are made for soliciting assent of the children and 
permission of their parents or guardians as set forth in H. in this section. 
[§46.408] 
 
G. Research not Otherwise Approvable that Presents an Opportunity to 
Understand, Prevent, or Alleviate a Serious Problem Affecting the Health or 
Welfare of Children (45 CFR 46.407) 
  
 If the IRB does not think the proposed research meets the requirements of the 
three immediately preceding conditions, research may only be approved if: 
 
1. The IRB finds that the research presents a reasonable opportunity to 
further the understanding, prevention, or alleviation of a serious problem 
affecting the health or welfare of children; and 
 
2. The Secretary of US DHHS, after consultation with a panel of experts in 
pertinent disciplines (for example: science, medicine, education, ethics, 
law) and following opportunity for public review and comment, has 
determined either: 
 
a. The research in fact satisfies the conditions in D., E., or F. in this 
section [§46.404, §46.405, or §46.406], as applicable, or  
  b. the following: 
 
1) the research presents a reasonable opportunity to further the 
understanding, prevention, or alleviation of a serious 
problem affecting the health or welfare of children; 
 
2) the research will be conducted in accordance with sound 
ethical principles; 
 
3) adequate provisions are made for soliciting the assent of 
children and the permission of their parents or guardians, as 
set forth in H. in this section. 
 
H. Requirements for Permission by Parents or Guardians and for Assent by 
Children (45 CFR 46.408) 
 
1. In addition to the determinations required under other applicable sections 
of this section, the IRB shall determine that adequate provisions are made 




the children are capable of providing assent. In determining whether 
children are capable of assenting, the IRB shall take into account the ages, 
maturity, and psychological state of the children involved. This judgment 
may be made for all children to be involved in research under a particular 
protocol, or for each child, as the IRB deems appropriate. If the IRB 
determines that the capability of some or all of the children is so limited 
that they cannot reasonably be consulted or that the intervention or 
procedure involved in the research holds out a prospect of direct benefit 
that is important to the health or well-being of the children and is available 
only in the context of the research, the assent of the children is not a 
necessary condition for proceeding with the research. Even where the IRB 
determines that the subjects are capable of assenting, the IRB may still 
waive the assent requirement under circumstances in which consent may 
be waived in accord with section K. of the Administrative Procedures for 
Human Subject Research. (45 CFR 46.116) 
 
2. In addition to the determinations required under other applicable parts of 
this section, the IRB shall determine, in accordance with and to the extent 
that consent is required by K. of the Administrative Procedures for Human 
Subject Research (§46.116), that adequate provisions are made for 
soliciting the permission of each child's parents or guardian. Where 
parental permission is to be obtained, the IRB may find that the 
permission of one parent is sufficient for research to be conducted under 
D. and E. in this section [§46.404 or §46.405]. Where research is covered 
by F. and G. in this section [§46.406 and §46.407] and permission is to be 
obtained from parents, both parents must give their permission unless one 
parent is deceased, unknown, incompetent, or not reasonably available, or 
when only one parent has legal responsibility for the care and custody of 
the child. 
 
3. In addition to the provisions for waiver contained in L. [§46.116] of the 
Administrative Procedures for Human Subject Research, if the IRB 
determines that a research protocol is designed for conditions or for a 
subject population for which parental or guardian permission is not a 
reasonable requirement to protect the subjects (for example, neglected or 
abused children), it may waive the consent requirements in A. in this 
section and paragraph 2. above provided an appropriate mechanism for 
protecting the children who will participate as subjects in the research is 
substituted, and provided further that the waiver is not inconsistent with 
federal, state, or local law. The choice of an appropriate mechanism would 
depend upon the nature and purpose of the activities described in the 
protocol, the risk and anticipated benefit to the research subjects, and their 





4. Permission by parents or guardians shall be documented in accordance 
with and to the extent required by L. [§46.117] of the Administrative 
Procedures for Human Subject Research.  
 
5. When the IRB determines that assent is required, it shall also determine 




1. Children who are wards of the state or any other agency, institution, or 
entity can be included in research approved under F. and G. in this section 
(§46.406 or §46.407) only if such research is: 
 
  a. Related to their status as wards; or 
 
b. Conducted in schools, camps, hospitals, institutions, or similar 
settings in which the majority of children involved as subjects are 
not wards. 
 
2. If the research is approved under paragraph 1. above, the IRB shall require 
appointment of an advocate for each child who is a ward, in addition to 
any other individual acting on behalf of the child as guardian or in loco 
parentis. One individual may serve as advocate for more than one child. 
The advocate shall be an individual who has the background and 
experience to act in, and agrees to act in, the best interests of the child for 
the duration of the child's participation in the research and who is not 
associated in any way (except in the role as advocate or member of the 










1. The regulations in this section are applicable to all biomedical and 
behavioral research involving prisoners conducted by any member of the 
University of Maine. 
 
2. All research involving prisoners as subjects must comply with any state or 
local laws limiting such research. 
 
3. The requirements of this section are in addition to those imposed under the 
other sections of the University of Maine Policies and Procedures for the 




 Inasmuch as prisoners may be under constraints because of their incarceration, 
which could affect their ability to make a truly voluntary and uncoerced decision 
whether or not to participate as subjects in research, it is the purpose of this 
section to provide additional safeguards for the protection of prisoners involved in 




 As used in this section: 
 
1. Prisoner means any individual involuntarily confined or detained in a 
penal institution. The term is intended to encompass individuals sentenced 
to such an institution under a criminal or civil statute, individuals detained 
in other facilities by virtue of statutes or commitment procedures that 
provide alternatives to criminal prosecution or incarceration in a penal 
institution, and individuals detained pending arraignment, trial, or 
sentencing. The University of Maine extends the term “prisoner” to 
include persons on pre-trial supervised release, on community supervision 
or on probation, or who is in any court-ordered deferred prosecution or 
diversion program. 
 
2. Minimal risk is the probability and magnitude of physical or psychological 
harm that is normally encountered in the daily lives, or in the routine 





D. Composition of IRB where Prisoners are Involved 
 
 In addition to satisfying the requirements in section F. of the Administrative 
Procedures for Human Subject Research, the IRB shall also meet the following 
specific requirements: 
 
1. A majority of the IRB (exclusive of prisoner members) shall have no 
association with the prison(s) involved, apart from their membership on 
the IRB. 
 
2. At least one member of the IRB shall be a prisoner, or a prisoner 
representative with appropriate background and experience to serve in that 
capacity, except that where a particular research project is reviewed by 
more than one IRB only one Board need satisfy this requirement. 
 
 A prisoner representative with appropriate background may include an attorney 
with experience in criminal defense or prisoners’ rights, a member of a prisoners’ 
rights advocacy organization, a chaplain or a counselor or other similar 
professional who deals, or has dealt with, prisoners. 
 
E. Additional Duties of the IRB where Prisoners are involved 
 
1. In addition to all other responsibilities prescribed for the IRB under this 
part, the IRB shall review research covered by this subpart and approve 
such research only if it finds that: 
 
a. The research under review represents one of the categories of 
research permissible under 306(a)(2); 
 
b. Any possible advantages accruing to the prisoner through his or 
her participation in the research, when compared to the general 
living conditions, medical care, quality of food, amenities and 
opportunity for earnings in the prison, are not of such a magnitude 
that his or her ability to weigh the risks of the research against the 
value of such advantages in the limited choice environment of the 
prison is impaired; 
 
c. The risks involved in the research are commensurate with risks that 
would be accepted by non-prisoner volunteers; 
 
d. Procedures for the selection of subjects within the prison are fair to 
all prisoners and immune from arbitrary intervention by prison 
authorities or prisoners. Unless the principal investigator provides 
to the IRB justification in writing for following some other 




group of available prisoners who meet the characteristics needed 
for that particular research project; 
 
e. The information is presented in language which is understandable 
to the subject population; 
 
f. Adequate assurance exists that parole boards, community release 
supervisors, and/or probation officers will not take into account a 
prisoner's participation in the research in making decisions 
regarding parole, community supervision, or probation, and each 
prisoner is clearly informed in advance that participation in the 
research will have no effect on his or her parole, community 
supervision, or probation; and 
 
g. Where the IRB finds there may be a need for follow-up 
examination or care of participants after the end of their 
participation, adequate provision has been made for such 
examination or care, taking into account the varying lengths of 
individual prisoners' sentences, and for informing participants of 
this fact. 
 
2. The IRB shall carry out such other duties as may be assigned by the 
Secretary of the US DHHS. 
 
3. The institution shall certify to the Secretary, in such form and manner as 
the Secretary may require, that the duties of the IRB under this section 
have been fulfilled.  
 
F. Permitted Research Involving Prisoners 
 
1. Biomedical or behavioral research not conducted or supported by DHHS 
may involve prisoners as subjects only if all of the conditions outlined 
above for general human subject research, and the special conditions for 
research with prisoners, are met.  
 
2. Biomedical or behavioral research conducted or supported by DHHS may 
involve prisoners as subjects only if: 
 
a. The institution responsible for the conduct of the research has 
certified to the Secretary that the IRB has approved the research 
under 45 CFR 46.305; and 
 
b. In the judgment of the Secretary, the proposed research involves 





1) Study of the possible causes, effects, and processes of 
incarceration, and of criminal behavior, provided that the 
study presents no more than minimal risk and no more than 
inconvenience to the subjects; 
 
2) Study of prisons as institutional structures or of prisoners as 
incarcerated persons, provided that the study presents no 
more than minimal risk and no more than inconvenience to 
the subjects; 
 
3) Research on conditions particularly affecting prisoners as a 
class (for example, vaccine trials and other research on 
hepatitis, which is much more prevalent in prisons than 
elsewhere; and research on social and psychological 
problems, such as alcoholism, drug addiction, and sexual 
assaults) provided that the study may proceed only after the 
Secretary has consulted with appropriate experts including 
experts in penology, medicine, and ethics, and published 
notice, in the FEDERAL REGISTER, of his intent to 
approve such research; or 
 
4) Research on practices, both innovative and accepted, which 
have the intent and reasonable probability of improving the 
health or well-being of the subject. In cases in which those 
studies require the assignment of prisoners in a manner 
consistent with protocols approved by the IRB to control 
groups which may not benefit from the research, the study 
may proceed only after the Secretary has consulted with 
appropriate experts, including experts in penology, 
medicine, and ethics, and published notice, in the 
FEDERAL REGISTER, of the intent to approve such 
research. 
 
3. Except as provided in paragraph F.2. of this section, biomedical or 
behavioral research conducted or supported by US DHHS shall not 







IV. Additional Protections for Pregnant Women, Human Fetuses and Neonates 
Involved in Research 
 
This subpart applies to all research involving pregnant women, human fetuses, neonates, 
and neonates of uncertain viability or nonviability. 
 
The exemptions noted in section C. of Administrative Procedures for Human Subject 
Research are applicable to this subpart. 
 
This policy does not alter any present or future state or local laws or regulations that may 
otherwise be applicable and which may provide additional protections for human 
subjects. This subpart is intended to include the laws of federally recognized American 
Indian and Alaska Native Tribal Governments. 
 
This policy does not alter any present or future foreign laws or regulations that may 
otherwise be applicable and which may provide additional protections for  human 
subjects. 
 
A.  Definitions 
 
1. Pregnancy encompasses the period of time from implantation until 
delivery. A woman shall be assumed to be pregnant if she test positive on 
a pregnancy test or exhibits any of the pertinent presumptive signs of 
pregnancy, such as missed menses, until the results of a pregnancy test are 
negative, or until delivery. 
 
 2. Fetus means the product of conception from implantation until delivery. 
 
3. Dead fetus means a fetus that exhibits neither heartbeat, spontaneous 
respiratory activity, spontaneous movement of voluntary muscles, nor 
pulsation of the umbilical cord. 
 
4. Delivery means complete separation of the fetus from the woman by 
expulsion or extraction or any other means. 
 
 5. Neonate means a newborn. 
 
6. Viable, as it pertains to a neonate, means being able, after delivery, to 
survive (given the benefit of available medical therapy) to the point of 
independently maintaining heartbeat and respiration. 
 






B. Research Involving Pregnant Women or Fetuses 
 
 Pregnant women or fetuses may be involved in research if all of the following 
conditions are met: 
 
1. Where scientifically appropriate, preclinical studies (including studies on 
pregnant animals) and clinical studies (including studies on nonpregnant 
women) have been conducted and provide data for assessing potential 
risks to pregnant women and fetuses. 
 
2. The risk to the fetus is caused solely by interventions or procedures that 
have the prospect of direct benefit for the woman or the fetus; or, if there 
is no prospect of benefit, the risk to the fetus is not greater than minimal 
and the purpose of the research is the development of important 
biomedical knowledge that cannot be obtained by any other means. 
 
 3. Any risk is the least possible for achieving the objectives of the research. 
 
4. If the research has the prospect of direct benefit to the pregnant woman, 
the prospect of a direct benefit both to the pregnant woman and the fetus, 
or no prospect of benefit for the woman nor the fetus when risk to the 
fetus is not greater than minimal and the purpose of the research is the 
development of important biomedical knowledge that cannot be obtained 
by any other means, her consent is obtained in accord with the informed 
consent provisions. 
 
5. If the research has the prospect of direct benefit solely to the fetus, then 
the consent of the pregnant woman and the father must be obtained in 
accord with the informed consent provisions, except that the father's 
consent need not be obtained if he is unable to consent because of 
unavailability, incompetence, or temporary incapacity or the pregnancy 
resulted from rape or incest. 
 
6. Each individual providing consent must be fully informed regarding the 
reasonably foreseeable impact of the research on the fetus or neonate. 
 
7. For children who are pregnant, assent and permission are obtained in 
accord with the informed consent provisions for children. 
 
8. No inducements, monetary or otherwise, can be offered to terminate a 
pregnancy.  
 
9. Individuals engaged in the research can have no part in any decisions as to 





10. Individuals engage in the research can have no part in determining the 
viability of a neonate. 
 
C. Research Involving Neonates 
 
1. A neonate, after delivery, that has been determined to be viable may be 
included in research by and in accord with the requirements described in 
sections Administrative Procedures for Human Subject Research and 
Additional Protections for Children Involved as Subjects in Research. 
 
2. Neonates of uncertain viability and nonviable neonates may be involved in 
research if all of the following conditions are met: 
 
a. Where scientifically appropriate, preclinical and clinical studies 
have been conducted and provide data for assessing potential risks 
to neonates. 
 
b. Each individual providing consent is fully informed regarding the 
reasonably foreseeable impact of the research on the neonate. 
 
c. Individuals engaged in the research will have no part in 
determining the viability of a neonate. 
 
d. Requirements outlined in 3. and 4. below have been met as 
applicable. 
 
3. Until it has been ascertained whether or not a neonate is viable, a neonate 
may not be involved in research unless the following additional conditions 
have been met: 
 
 a. IRB determines that: 
 
1) The research has the prospect of enhancing the probability 
of survival of the neonate to the point of viability, and any 
risk is the least possible for achieving that objective, or 
 
2) The purpose of the research is the development of 
important biomedical knowledge that cannot be obtained 
by other means, and there will be no added risk to the 
neonate resulting from the research. 
 
b. The legally effective informed consent of either parent of the 
neonate or, if neither parent is able to consent because of 
unavailability, incompetence, or temporary incapacity, the legally 
effective informed consent of either parent's legally authorized 




Administrative Procedures for Human Subject Research, except 
that the consent of the father or his legally authorized 
representative need not be obtained if the pregnancy resulted from 
rape or incest. 
 
4. After delivery, nonviable neonates may not be involved in research unless 
all of the following conditions are met: 
 
 a. Vital functions of the neonate will not be artificially maintained. 
 
b. The research will not terminate the heartbeat or respiration of the 
neonate. 
 
c. There will be no added risk to the neonate resulting from the 
research. 
 
d. The purpose of the research is the development of important 
biomedical knowledge that cannot be obtained by other means. 
 
e. The legally effective informed consent of both parents of the 
neonate is obtained. However, if either parent is unable to consent 
because of unavailability, incompetence, or temporary incapacity, 
the informed consent of one parent of a nonviable neonate will 
suffice, except that the consent of the father need not be obtained if 
the pregnancy resulted from rape or incest. The consent of a legally 
authorized representative of either or both of the parents of a 
nonviable neonate will not suffice. 
 
D. Research Involving After Delivery, the Placenta, Dead Fetus, or  
Fetal Material 
 
1. Research involving after delivery, the placenta, dead fetus, macerated fetal 
material; or cells, tissues, or organs excised from a dead fetus, must be 
conducted in accord with applicable federal, state, or local laws and 
regulations regarding such activities. 
 
2. If information associated with 1. of this section is recorded for research 
purposes in a manner that living individuals can be identified, directly or 
through identifiers linked to those individuals, those individuals are 
considered research subjects. 
 
 
WHAT ARE THE MAJOR CHANGES IN THE REVISED COMMON RULE?  
Changes to definitions: 
• The definition of research now excludes journalistic endeavors, oral histories and data collection 
for professional non-research purposes (examples, criminal justice activities and data collection 
for national security purposes). 
• The human subject definition is changed to include identifiable biological specimens. 
Changes to Continuing Review Regulations: 
• As part of the new regulations, annual continuing reviews are eliminated for all new expedited 
studies approved on or after January 21, 2019, unless the IRB determines that a continuing 
review should be required for a specific study.  
• Continuing review is also not required if the research was initially approved by a convened 
meeting and has progressed to the point that it involves only one or both of the following 
activities: 
 Data analysis (including analysis of identifiable information or identifiable biospecimens) 
 Access to follow-up clinical data from procedures that subjects would undergo as part of 
clinical care 
• Full board studies will still need annual continuing review approval.  
• Please note that even if a continuing review is not required modifications and reportable events 
(adverse events and/or unanticipated problems) must be submitted to the IRB for review. 
Changes to Consent Forms: 
Long consent forms and/or consent forms for federally funded studies will require a concise summary: 
• The concise summary is meant to be brief. The purpose of the summary is for the participant to 
decide why he/she may want to participate but should also include information on why he/she 
may not want to participate in the study (for example a huge time commitment or other risks). 
The summary should not include all foreseeable risks but the risks that would be most likely or 
most severe to the participant. 
• The summary should include the following 5 elements: 
1) A statement that the project is research and that it is voluntary. 
2) A summary of the research (purpose, overview of procedures etc.) 
3) Any foreseeable risks or discomforts 
4) Any expected benefits to participants (if applicable) 
5) If applicable, alternative procedures to course of treatment 
You will find concise summary examples on the Forms and Samples page. 
Changes to the Exempt categories: 
Exempt 1 – Normal educational practices - Revised 
• The following restriction was added “not likely to adversely impact student’s opportunity to 
learn required educational content, or assessment of educators who provide instruction”. 
Exempt 3 Benign Behavioral Intervention – New category 
• The former exempt category 3 was eliminated and replaced with a category granting exemption 
to studies involving only “benign behavioral interventions” with adult subjects. The data must 
be anonymous or non-sensitive, or have sufficient protections in place to ensure data security. 
• Research involving benign behavioral interventions in conjunction with the collection of 
information from an adult subject through verbal or written responses (including data entry) or 
audiovisual recording if the subject prospectively agrees to the intervention and information 
collection. 
• Benign behavioral interventions are defined as: “brief in duration, harmless, painless, not 
physically invasive, not likely to have a significant adverse lasting impact on the subjects, and the 
investigator has no reason to think the subjects will find the interventions offensive or 
embarrassing.” 
              Examples that would fit under Category 3: 
1. having subjects play an online game 
2. having subjects solve puzzles under various noise conditions 
3. playing economic games 
 
• If a study involves deception, it can be exempt under category 3 if the participants are told 
during the recruitment/consent process that there is an element of deception in the study, and 
they agree to participate knowing this. 
 
Exempt 7 – Not implemented at the University of Maine at this time 
• Allows for the storage of data and/or specimens in a repository, with identifiers maintained, 
that were collected under an approved IRB protocol with Broad Consent* for future secondary 
use research. 
Exempt 8 - Not implemented at the University of Maine at this time 
• Allows for secondary research use/analysis of identifiable data/biospecimens that were 
collected under an approved IRB protocol with Broad Consent* 
* Broad consent is an alternative consent process for use only for the storage, maintenance and 
secondary use of identifiable private information or biospecimens for future research (yet to be 
determined). See HHS Recommendations for Broad Consent Guidance for more information on broad 
consent. 
At this time the University of Maine (similar to many other institutions) will not use broad consent. 
Changes to review of cooperative research: 
• Research conducted by investigators at multiple research sites must rely on a single IRB of 
record (sIRB). However, implementation for this is January 20, 2020. 
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Anonymous vs. Confidential 
When collecting data (most often from surveys), researcher will say that the data are 
anonymous or confidential. 
The two words mean di fferent things, and it is important for the participant, their 
protection, and their willingness to participate that the correct term is used. 
Anonymous 
1. The researcher is not collecting any unique identifiers from individual subjects (for 
example, name, email, phone number). 
2. The researcher is not collecting identifiers that, if combined, would be l ikely to 
identify a participant (for example, age, race, occupation, years in that occupation in 
a relatively small sample of participants). 
In short, anonymous data can never be linked to an individual. 
Confidential 
1. Confidential data means that the researchers will be able to identify the 
participants. But it also means that the data w ill never be reported in a way that 
allows a participant's identity to be known (e.g., responses are combined w ith those 
of other part icipants and reported in aggregate form). 
In short, an activity is confidential if participants provide identifying information but the 
connection 
between participant and results is not shared. 
Data cannot be both anonymous and confidential. 
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Continuing Review Instructions 
In accordance w ith Federal Regulations, all Full Board and some expedited projects 
(determined by the IRB) must undergo a continuing review. Investigators must submit a 
protocol summary, a status report on the progress of the research, and current/new 
consent forms. Although investigators w ill receive a request from the IRB Office for 
review information, it is their responsibility to submit review information in sufficient time 
to allow for IRB review (at least three weeks prior to the approval expiration). 
Where continuing review is not required. the IRB requires submission of a progress report 
at per iodic intervals. At the time of initial approval, the IRB will specify the interval for 
submission in the approval notice. The IRB may set the interval for reporting at one, two, 
or three years. Future reporting requirements w ill be assessed during each review and 
may be changed at any time. The IRB office w ill se nd the Pl a reminder for when the 
progress report is due. 
Regardless of the requirement set by the I RB for reporting study progress (continuing 
review or progress report), investigators still must inform the IRB of any changes to the 
protocol and inform the IRB of reportable events. 
Please respond to the fo llowing questions: (Please type your responses on a separate 
sheet of paper.) 
1. Include a br ief protocol summary. (This should be no more than one or two pages.) 
2. Status Report Includes: 
1. Indicate the number of subjects accrued during this reporting period and, for 
ongoing stud ies, the total number accrued. 
2. Report al l changes in personnel involved with the study. 
3. Include a description of any: adverse events or unanticipated problems 
involvinP r isks to <;11h iP.cts or othPr<;. w it h rlr;:iw;:il o f s11hiP.cts from thP rPsP.;:irch . 
or complaints about the research. 
4. Include a summary of any recent li tera ture, findings obtained thus far, 
amendments or modifications to the research since the last review, and any 
other relevant information, especially information about r isks associated with 
the research. 
3. Attach a copy of the current, IRB-approved informed consent document (stamped 
copy). Also include a "clean" copy for approval and stamping. 
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To ensure confidentiality of identif iable, electronic data, the Institutional Review Board 
(IRS) requires that the electronic key linking participants' identit ies to their data be 
encrypted. This is accomplished by the use encryption software. The IRS contacted 
Information Technologies for advice on encryption software, and below is their response: 
The Information Security Office requires as a standard, AES 128 or AES 256 encrypt ion for 
data at rest. By far the most popular encryption software employed in the UMS is 
BitLocker for Windows and FileVault for Macs. There isn't a cross-platform solution that 
we are aware of. 
• Windows: Bit Locker is included with Windows 8 and 8.1 and Windows 7 Enterpr ise 
and Ultimate vers ions (it is not known what t he cost is for other versions of 
Windows 7). An open source alternative is Diskcrytor. 
• Macs: FileVault2 is included with OS X version 10.7 and higher (the only supported 
versions of OS X). 
• Linux: The most apparent encryption to us is Linux Uni fied Key Setup (LUKS). 
There are many alternatives, including some that are not intended for full disk encryption, 
but suitable for file encryption. If there is a particular alternative that would someone 
would like to discuss, contact Information Technologies. 
Remember! 
• This is for ELECTRONICALLY COLLECTED/STORED IDENTIFIABLE DATA. 
• If data are collected without identifiers (i.e., anonymous data), encryption is not 
required. 
• Most often, the only data that must be encrypted is the computer file that is the key 
f 
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coded, but the key is in paper format (i.e., handwritten), there is nothing to encrypt 
(obviously!). 
• If electronic, identifiable data are not coded, the eritire dataset must be encrypted. 
This might occur if: a) the dataset includes participants' names (usually not done), 
orb) the data could be identifiable because o f the type of data collected (e.g., some 
demographics can identify people). 
Contact the I RB Office with ~uestions about the requirement, but contact Information 
Technologies for assistance in selecting/using an encryption program. 
ID'lm 
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University of Maine research studies often include measures that screen for depression (e.g., 
Beck Depression Inventory (BDI), Children’s Depression Inventory (CDI), Structured Clinical 
Interview).  The Institutional Review Board for the Protection of Human Subjects (IRB) has 
developed this guidance to assist researchers as they develop and write their human subjects 
application proposing to use such measures.  The IRB’s goal is to be sure that applications for 
studies assessing depression and/or suicidality consistently contain information on the use of 
such measures, as well as plans for follow-up with participants whose responses raise concerns 




1. Information to be included in an IRB application where adult participants are 
anonymous: 
 
If research is proposed where data collection will be anonymous (e.g., on-line surveys, 
paper/pencil surveys): 
 
• The summary section should name the instrument(s) to be used and why (this is not a 
new requirement).  If a depression measure will be used that includes a suicide item 
and the researcher does not wish to include the suicide item, he/she must explain why.  
The reason must be based on research goals (e.g., research goal is to assess only 
depressive symptoms and not specifically suicide risks).    
 
• The consent form must include referrals for mental health services (following the 
referral template found on the IRB website).  In addition to the consent form, referrals 
should repeated at the end of the survey. 
 
2. Information to be included in an IRB application where adult participants’ 
identities are known: 
 
• The summary section should name the instrument(s) to be used and why (this is not a 
new requirement).   If a depression measure will be used that includes a suicide item 
and the researcher does not wish to include the suicide item, he/she must explain why.  
The reason must be based on research goals (e.g., research goal is to assess only 




• The risk section must, in addition to stating that referrals for mental health services 
will be provided, describe the researcher’s plan for follow-up in situations where a 
participant’s responses/score indicate a high level of depressive symptoms and/or 
intent to harm him/herself.   
 
• The consent form (risk section) must, in addition to listing referrals in case they 
become upset (following the referral template found on the IRB website), inform the 
potential participant that the researcher will follow-up with them if their responses to 
the questionnaires cause the researcher to be concerned for their well-being.     
 
Instructions for follow-up: 
 
• In the case of follow-up for depressive symptoms, the researcher should follow-up 
as soon as possible after the measures are completed.  For studies done in the lab, if 
the instruments could be scored quickly, a discussion could take place in the lab.  
Follow-up communication via email or phone is also acceptable.  The following text 
may be used for the follow-up communication (in person or via email/phone):    
 
o “I am [investigator/faculty supervisor] of the research study that you recently 
completed.  From your answers to the questionnaires, you seemed to be feeling 
quite down.  You were provided with some information about counseling 
services, but I wanted to follow-up and encourage you to contact those services or 
your primary care provider.”  Repeat the Counseling Center information for 
UMaine students and the community resources that were originally given 
community participants.  
 
o Researchers will need to be sure contact information is obtained at the start of the 
study (especially critical for community participants).   This could be a sentence 
at the end of the consent form asking for preferred method of contact. 
 
• In the case of follow-up for responses indicating suicidality or imminent harm: 
(regardless of the participant’s total score), the researcher must follow-up the same 
day the measure is taken.  For studies done in the lab, if the instruments could be 
scored quickly, a discussion could take place in the lab.  Follow-up communication 
via email or phone is also acceptable.  The following text may be used for the follow-
up communication (in person or via email/phone):   
 
o “I am [investigator/faculty supervisor] of the research study that you recently 
completed.  From your answers to the questionnaires, I am concerned that you 
may harm yourself.  You were provided with some information about counseling 
services, but I wanted to follow-up and encourage you to contact those services or 
your primary care provider.”  Repeat the Counseling Center information for 
UMaine students and the community resources that were originally given 
community participants.  If the researcher feels immediate intervention is 
required, contact the Counseling Center (UMaine Students only) or Community 




o Researchers will need to be sure contact information is obtained at the start of the 
study (especially critical for community participants).  This could be a sentence at 




1. Information to be included in an IRB application where minor participants are 
anonymous: 
 
If research is proposed where data collection will be anonymous (e.g., on-line surveys, 
paper/pencil surveys): 
 
• The summary section should name the instrument(s) to be used and why (this is not a 
new requirement).  If a depression measure will be used that includes a suicide item and 
the researcher does not wish to include the suicide item, he/she must explain why.  The 
reason must be based on research goals (e.g., research goal is to assess only depressive 
symptoms and not specifically suicide risks, school district will not allow question to be 
used, etc.).    
 
• Referrals for mental health services must be provided in the consent form to 
parent/guardian (following the referral template found on the IRB website). 
 
2. Information to be included in an IRB application where minor participants’ 
identities are known: 
 
• The summary section should name the instrument(s) to be used and why (this is not a 
new requirement).  If a depression measure will be used that includes a suicide item 
and the researcher does not wish to include the suicide question, he/she must explain 
why.  The reason must be based on research goals (e.g., research goal is to assess only 
depressive symptoms and not specifically suicide risks, school district will not allow 
question to be used, etc.).   
 
• The risk section must, in addition to stating referrals for mental health services will be 
provided, describe the researcher’s plan for follow-up in situations where a minor’s 
responses/score indicate a high level of depressive symptoms or intent to harm 
him/herself.  (If the study is conducted at a school, it may be the case that 
parents/guardians are informed that the guidance counselor will be informed and 
he/she will follow up with them.)   
 
• The parental consent form (risk section) must, in addition to listing referrals in case 
their son/daughter become upset (following the referral template found on the IRB 
website), inform the parent/guardian that the researcher will follow-up with them if 
their child’s responses to the questionnaires cause the researcher to be concerned for 
his/her well-being.  (If study is conducted at a school, it may be the case that 
4 
 
parents/guardians are informed that the guidance counselor will be informed and 
he/she will follow up with them.)  The assent script should tell children that if the 
researcher is concerned about how they are feeling, they will talk with their parent (or 
guidance counselor). 
 
Instructions for Follow-up: 
 
• In the case of follow-up for depressive symptoms.  The parent/guardian is most 
often the one who will be contacted with concerns.  When research is conducted in 
schools, it is often the case that the guidance counselor is the first point of contact.  
Researchers need to check with schools to design follow-up procedures.  For studies 
done in the lab, if the instruments could be scored quickly, a discussion with the 
parent/guardian could take place in the lab.  Follow-up communication via email or 
phone is also acceptable.  The following text may be used for the follow-up 
communication (in person or via email/phone):   
 
o “I am [investigator/faculty supervisor] of the research study that your 
son/daughter recently completed.  From his/her answers to the questionnaires, 
he/she seemed to be feeling quite down.  You were provided with some 
information about counseling services, but I wanted to follow-up and 
encourage you to contact those services or your primary care provider.”  
Repeat the community resources that were originally given community 
participants.  
 
o Researchers will need to be sure contact information is obtained at the start of 
the study.  This could be a sentence at the end of the consent form asking for 
preferred method of contact. 
 
• In the case of follow-up for responses indicating suicidality or imminent harm.  
The parent/guardian is most often the one who will be contacted with concerns.  
When research is conducted in schools, it is often the case that the guidance counselor 
is the first point of contact.  Researchers need to check with schools to design follow-
up procedures.  For studies done in the lab, if the instruments could be scored quickly, 
a discussion with the parent/guardian could take place in the lab.  Follow-up 
communication via email or phone is also acceptable.  The following text may be 
used for the follow-up communication (in person or via email/phone):   
 
o  “I am [investigator/faculty supervisor] of the research study that your 
son/daughter recently completed.  From his/her answers to the questionnaires, 
I am concerned that he/she may have thoughts about harming him/herself.  
You were provided with some information about counseling services, but I 
wanted to follow-up and encourage you to contact those services or your 
primary care provider.”  Repeat the community resources that were originally 




o Researchers will need to be sure contact information is obtained at the start of 
the study.  This could be a sentence at the end of the consent form asking for 
preferred method of contact. 
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It is important to remember that the investigator may not determine on his/her 
own that the proposed research is exempt from further review. An application 
must be submitted to the IRB. 
Research Activities that may be Exempt from Further Review 
Research involving chi ldren*, fet uses, prisoners, m entally disabled persons, or other adult 
subjects of diminished autonomy is subject to special restrictions. For adult subjects of 
undiminished autonomy, capable of making a truly voluntary and uncoerced decision 
whether or not to participate as subjects in research, the categories of research exempt 
from further review requirements are: 
1. Research conducted in established or commonly accepted educational settings 
involving normal educational practices, such as: 
o research on regular and special education instructional st rategies; or 
o research on the effectiveness of or the comparison among instructional 
techniques, curr icula, or classroom management methods 
2. Research involving the use of educat ional tests (cognitive, diagnostic, apt itude, 
achievement) survey procedures, interview procedures or observation of public 
behavior, unless: 
o information obtained is recorded in such a manner that human subjects can 
be identified, directly or through identifiers linked to the subjects; and 
o any disclosure of the human subject s' responses outside the research could 
reasonably place the subjects at r isk of criminal or civil liability or be damaging 
to the subjects financial standing, employability, or reputation . 
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responses, (including data entry or audiovisual recording) from adult subjects who 
prospectively agrees and ONE of the following met: 
o Recorded information cannot readily identify the subject (directly or 
indirectly / Ii n ked); 
o Any disclosure of responses outside of research would NOT reasonably place 
subject at r isk (criminal, liabil ity, financial, employability, educational 
advancement, reputation); OR 
o The information obtained is recorded by the investigator in such a manner that 
the ident ity of t he human subjects can readily ascertained, directly or ind irectly 
through identifiers linked to the subjects, and an IRB conducts a limited IRB 
review to make the determination requ ired. 
4. Research involving the collection or study of existing data, documents, records, 
pathological specimens, or diagnostic specim ens if these sources are publicly 
available or if the information is recorded by the investigator in such a manner that 
subjects cannot be identi fied, directly or through identifiers linked to the subjects. 
5. Research and demonstration projects which are conducted by or subject to the 
approval of department or agency heads, and which are designed t o study, evaluate, 
or otherwise examine: 
o public benefit or service programs; 
o procedures for obtaining benefits or services under those programs; 
o possible changes in or alternatives to those programs or procedures; or 
o possible changes in methods or levels o f payment for benefits or services 
under those programs. 
6. Taste and food quality evaluation and consum er acceptance studies: 
o if wholesome foods without additives are consumed; or 
o if a food is consumed that contains a food ingredient at or below the level and 
for a use found to be safe, or agr icultural chemical or environmental 
contaminant at or below the level found to be safe, by t he Food and Drug 
Administration or approved by the Environmental Protection Agency or the 
Food Safety and Inspection Service of the U.S. Department of Agriculture. 
•when the humon subjects are children, only five of the above categories apply. Exemption 2 (for research involving 
survey or interview procedures or observations of public behavior), does not apply to research with children, except 
for research involving observation of public behavior when the investigator(s) do not participate in the activities 
being observed. 
IDlUII n D @) 
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Considerations When Collecting Student Records 
When collecting education records from students (K-12 and higher education) The FamilY. 
Educational Rights and Pr ivacY. Act (FERPA) and the Protection of PuP-ils Rights 
Amendment (PPRA) are two laws that must be taken into consideration. 
FERPA (34 CFR Part 99) is a Federal law that protects the privacy of student education 
records. The law applies to all schools that receive funds under an applicable program of 
the U.S. Department of Education. It is t he invest igator's responsibility to be aware of 
when these laws would affect their research and to be aware of his/her obligations 
with the school. 
PPRA (20 U.S. Code § 1232h) is a federa l law that affords certain rights to parents of minor 
students with regard to surveys t hat ask questions of a personal nature. 
FERPA 
Generally, schools must have written permission from the parent or eligible student in 
order to release any information from a student's education record. 
Exceptions to FERPA 
1. FER PA allows schools to d isclose those records, w ithout consent, to the following 
part ies or under t he 
following conditions: 
o School officials with legitimate educational interest; 
o Other schools to which a student is transferr ing; 
o Speci fied offi cials for audit or evaluation purposes; 
o Appropriate parties in connection with f inancial aid to a student; 
o Accrediting organizations; 
o To comply with a judicial order or lawfu lly issued subpoena; 
o Appropriate offic ials in cases of health and safety emergencies; and 
o State and local authorities, within a juvenile justice system, pursuant to specifi c 
State law 
o Organizations conducting certain studies for or on behalf of the school. 
2. Schools may disclose, without consent, "directory" information such as a student's 
name, address, telephone number, date and place of birth, honors and awards, and dates 
of attendance. However, schools must tell parents and eligible students about directory 
information and allow parents and eligible students a reasonable amount of time to 
request that the school not disclose directory information about them. 
Researchers should contact each educational institution from which he/she 
proposes to access student records and follow that institution's FERPA policy and 
procedures when accessing and proposing to disclose any directory information. 
3. Schools may disclose information from student education records without prior 
consent if all personally identifiable information has been removed from the records, 
provided that the institution has made a reasonable determination that a student's 
identity would not be personally identifiable, whether through single or multiple releases, 
and taking into account other reasonably available information. 
Note that it is t he educational institution t hat holds the student records that has to 
make t his determination. 
PPRA 
The PPRA applies to the programs and activities of a State educational agency (SEA), local 
educational agency (LEA), or other recipient of funds under any program funded by t he 
U.S. Department of Education. It governs the administration to students of a survey, 
analysis, or evaluation that concerns one or more of the following eight protected areas: 
• politica l affi liations or beliefs of the student or the student's parent; 
• mental or psychological problems of the student or the student's family; 
• sex behavior or attitudes; 
• il legal, anti-social, self-incrim inating, or demeaning behavior; 
• critical appraisals of other individuals with whom respondents have close family 
relationships; 
• legally recognized privileged or analogous relationships, such as those of lawyers, 
physicians, and 
ministers; 
• religious practices, affiliations, or beliefs of the student or student's parent; or, 
• income (other than that required by law to determine eligibility for participation in a 
program or 
for receiving financial assistance under such program). 
Researchers whose research is subject to t he PPRA should review t he policies of t he 
local educational 
agency early in the study design process. 
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Guidelines for Class Projects Involving Human 
Subjects 
These guidelines are intended to assist instructors in determining when class projects 
meet the definition of research with human subjects and require review by the University 
of Maine's Institutional Review Board for the Protection of Human Subjects (i.e., IRB). 
For questions or additional guidance, contact the IRB Office. 
For clarification, the following are NOT class projects; if they involve human 
subjects, they are considered research and must be reviewed and approved by the 
IRB: 
• Senior research projects conducted within the framework of the senior capstone 
experience 
• Honors theses 
• Master's theses 
• Doctoral dissertations 
• Instructors should meet with students as soon as possible and go over these 
guidelines to determine if the proposed class project could be considered research. 
• If there is even a remote possibility that a class project may fal l under the defin ition 
of research, instructors are advised to submit a human subjects review application 
with the student to the IRB. Remember, class projects that involve protected 
populations, collection of sensitive information, or entities covered by another 
IRB, e.g., EMMC, Penobscot Nation (as defined at the end of this document) 
require IRB review and approval. 
If the class project meets the definition of research: 
The instructor should meet w ith the student to prepare t he human subjects review 
application. 
• If the project goes before t he Full Board at its monthly meeting, the instructor must 
attend the IRB meeting w ith the student. 




• Class projects t hat involve systematic collection of data and for which the design or 
objective is to develop or contr ibute to generalizable knowledge are considered 
research. In other words, if the student (or instructor) plans to use the data outs ide 
of t he class, the project is considered research and requires IRS review. 
• Marketing studies - if students collect data for a company or entity (e.g., restaurant) 
as part of a class marketing project, IRB review would NOT be required as long as 
these t hree conditions are met: 
■ Students are simply giving the collected data to the company, and 
the data are for the company's internal use only (e.g., the data will 
not be presented in a public forum). 
■ Students have no plans to use t he data for an honors thesis, 
research presentation at co1ferences, master's thesis, or 
d issertation. 
■ The project does NOT involve protected populations, collection of 
sensit ive information, or involve entities covered by another IRB, 
e.g., EM MC, Penobscot Nation (as defined at the end of this 
document). 
• Class projects that are designed solely with the objective of providing students with 
training about and experience with research methods are not considered research. 
In cases in which data will not be used outside of the classroom context and data 
will be dest royed upon completion of t he project, these projects are not 
considered research and do not require IRS review. HOWEVER, if the instructor 
allows a student to design a class project t hat involves protected populations, 
collection of sensit ive information, or entit ies covered by another IRS, e.g., 
EMMC, Penobscot Nation (as defined at the end of this document), IRS review 
and approval are required. 
Training Requirements 
Instructors assigning class projects are required to complete the IRB training tutorial. 
• Instructors should require students to complete the IRB training tutorial as part of 
the learning experience, even in cases when the student's project does not have to 
obtain IRB approval. 
Instructors' Responsibilities 
• Instructors should meet with students as soon as possible and go over these 
guidelines to determine if the proposed class project could be considered research. 
• If there is even a remote possibility that a class project may fall under the defin ition 
of research, instructors are advised to submit a human subjects review application 
with t he student to the IRB. Remember, class projects t hat involve protected 
populations, collection of sensitive information, or ent ities covered by another 
IRS, e.g., EMMC, Penobscot Nation (as defined at the end of this document) 
require IRB review and approval. 
If the class project meets the definition of research: 
The instructor should meet w ith the student to prepare the human subjects review 
application. 
• If the project goes before the Full Board at its monthly meeting, the instructor must 
attend the IRB meeting w ith the student. 
If the class project does not meet the definition of research 
• It is the responsibility of the instructor to ensure that the student project does not 
meet the definit ion of research. 
• It is the responsibility of the instructor to ensure that the class project is conducted 
according to the ethical standards of the relevant discipline. 
• Remember that from the participant's viewpo int, giving out personal information 
does not differ for a class assignment or a research project. Personal information is 
personal information. Instructors should adv ise students to identify the project to 
participants as a class assignment and be sensit ive to the personal nature of the 
obtained information. Labeling the class project as "research" is inaccurat e and 
misleading to participants. 
• Students should inform participants that data will be destroyed after their 
assignment or class project is completed (end of the semester). 
• Inst ructors are advised to tell students that data from human subjects should not 
contain any personal, identifying information whenever possible. 
• All class projects must include informed consent language that closely fo llows the 
guidelines. Information on what to include i11 a consent form/script is described 
below. For an on-line survey, th is would be th e first page of the survey or in the 
email post. 
• The IRB is available to give feedback on any p roposed class project not meeting the 
definition of research, even though the IRB would not officially act on the project. 
Any class project that meets the definit ion of research or involves protected populations, 
collection of sensit ive information, or involves entities covered by another IRB, e.g., 
EMMC, Penobsoct Nation must be reviewed and approved by the IRB (contact the IRS 
Office). Approval cannot be granted retroactively under any circumstances for any 
research project. 
We would like to acknowledge the use of /RB guidelines on class-related projects from both 
Pennsylvania State University and Duke University. 
Information to Include in Email Postings or Verbal Scripts for Informed Consent 
When information is collected for a class project that does not meet the definit ion of 
research (as defined by the federal regulations) and does not require approval by the IRB, 
it is still important to "inform" the participants about the class project, whether posted as 
an email message or presented verbally in person . Make sure the participant is told: 
• The identity of t he student (introduce yourself!). (This may not always be necessary, 
as many students enlist the help of friends or family to collect data for a class 
project.) 
• They must be at least 18 years of age to part icipat e. 
• It is a class project. (Give a little information, e.g., This is for my business class, I am 
t rying to see if there is a relationship between X and Y.) 
• What they will be asked to do ("I would like to ask you some questions about why 
you chose to attend the University of Maine. If there are any questions you don't 
want to answer, it is fine to skip them."). 
• How long the interview, survey, etc., may take to complete. 
• What w ill happen to the information collected ("The information w ill be used to write 
my paper for the class, and I will give a presentation in class. All of my notes, 
surveys, etc., will be destroyed when the sem ester is over.") 
• If they w ill be identified: examples: "I will not write your name on my notes"; "Do not 
write your name on the survey;" "I will not use your name in my paper." 
• The student's and instructor's contact inform ation if they have any questions 
(provide phone number/email). 
Here is an example of a posting for a survey: NOTE: If you use Qualtrics, 
SurveyMonkey, etc., the consent information shoUJld also be the first page of the survey. 
This survey is for a class research project in (Course #/Name.) Our names are XXXXX. We 
are conducting a survey about XXX for a report and a class presentation. 
Participation: You need to be at least 18 to participate. Participation is voluntary. You can 
stop the survey at any time or skip questions. The survey should take only about 10 
minutes to complete. 
Risks: Risks for participating are minor- just your t ime. 
Confidentiality: We are not collecting any names, so the survey is anonymous. 
Presentation: We are going to use the information for a class presentation and then 
destroy survey data. 
Contact Informat ion: Please contact us if you have any questions: names/emails 
Instructor: name and contact information) 
Protected Populations/Sensitive lnformat1on/Other Except10ns 
* Protected Populations - Examples include, but are not limited to: 
• Children/Minors (under the age of 18) (Exception - projects conducted in 
established or commonly accepted educational settings involving normal 
educational practices. Contact IRB office for guidance.) 
• Pr isoners (now includes non-publicly available secondary data) 
• Pregnant women 
• Fetuses and products of labor and delivery 
• People with diminished capaci ty to give consent 
• Mentally or physically challenged individuals 
*Sensitive Information - Examples include, but are not limited to: 
• Information relating to an individual's psychological well being or mental health 
• Information relating to sexual attitudes, preferences, or practices 
• Information relating to the use of alcohol or drugs 
• Information relating to illegal behavior 
• Information that if released could reasonably place the individual at risk of criminal 
or civil liabil ity or be damaging to the individual's financial standing, employability, or 
reputation 
• Information that would normally be recorded in a patient's medical record and the 
d isclosure could reasonably lead to discr imination, stigmatization, etc. 
* Other: 
• Be aware that there could be instances wher e a class project could fall under the 
authority of another I RB such that these guidelines would not apply, e.g., studies 
proposed to involve Eastern Maine Medical Center (EMMC) staff or patients, 
members/citizens of t he Penobscot Nation (specifically targeted). 
* Instructors/students who are unsure of whether a proposed project involves a protected 
population or sensitive information should contact the IRB Office. 
Flow Chart for Guidance on Whether a Class Project Renuires IRB Review (PDF) 
 
Is the project a senior capstone 
project, honors thesis, masters 
thesis, or doctoral dissertation? 
Is t he project solely for a class 
assignment w here data will not 
be used outside of t he classroom 
context and data are destroyed 
at t he end of t he project w it h no 
further use? 
Does t he project involve 
protected populations, collection 
of sensitive information, or 
entitles covered by another IRS, 
e.g., EMMC, Penobscot Nation? 
(See examples on next page.) 
~ ._I _ I_R_B_R_e_v_ie_w_R_e_q_u_ir_e_d____, 
~ ._r _ IR_B_R_e_v_ie_w_R_e_q_u_ir_ed_~ 
~ ~I __ M_ ar_k_et_in_g_S_tu_d_y_?_~ 
◊ 
MarketingStudy(studentscollectingdata for a businessl: 
(11 Students are simply givingthecollected d ata to the 
business, and the dataarefor the business's internal use only 
(e.g., t he dot.will not be present ed in a public forum). 
(2) Students hiM! no plans to US1!th<!datator an honors thesis, 
research presentationatconferences, master's thesis, or 
dissertation. 
(3) The project does NOT involve protected populations or 
sensitive information (asdefined at the end of this document). 
All 3 conditions met, 
IRB review NOT required 
Any of the 3 conditions not 
met, IRB review required 
~ [ IRB Review NOT Required 
~ [ IRB Review Required 
Examples of Protected Populations/Sensitive Areas/Other Exceptions 
 
Protected Populations – Examples include, but are not limited to: 
• Children/Minors (under the age of 18) (Exception – projects conducted in established or 
commonly accepted educational settings involving normal educational practices.  Contact IRB 
office for guidance.)  
• Prisoners (now includes non-publicly available secondary data) 
• Pregnant women 
• Fetuses and products of labor and delivery 
• People with diminished capacity to give consent  
• Mentally or physically challenged individuals 
 
Sensitive Information – Examples include, but are not limited to: 
• Information relating to an individual’s psychological well-being or mental health 
• Information relating to sexual attitudes, preferences, or practices 
• Information relating to the use of alcohol or drugs 
• Information relating to illegal behavior 
• Information that if released could reasonably place the individual at risk of criminal or civil liability 
or be damaging to the individual’s financial standing, employability, or reputation 
• Information that would normally be recorded in a patient’s medical record and the disclosure 
could reasonably lead to discrimination, stigmatization, etc. 
 
Other –  
 
• Be aware that there could be instances where a class project could fall under the authority of 
another IRB such that these guidelines would not apply – e.g., studies proposed to involve 
Eastern Maine Medical Center (EMMC) staff or patients, members/citizens of the Penobscot 
Nation (specifically targeted).   
 
  
Instructors/students who are unsure of whether a proposed project meets the guidelines for class 
projects should contact the IRB Office at 1-2657, email: umric@maine.edu.  Remember, the IRB will not 
conduct retroactive reviews, so ask questions early and plan early!  Conducting research with human 
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PER GÅRDER, PH.D., P.E.  
302 Boardman Hall 
University of Maine 
Orono, ME 04469-5711 
Telephone 1 207 581 2177 
E-mail address: Garder@Maine.edu
CIE 424         URBAN TRANSPORTATION PLANNING      SPRING 2010  
Instructor:   Per Gårder, contact me by First Class or e-mail Garder@Maine.edu or, if important, cell phone 
852-8268. Open door office policy 
Text:  Urban Transportation Planning, Second Edition by Michael D. Meyer & Eric J. Miller. Publisher:  
McGraw-Hill, Inc. ©: 2001 
Objectives: To teach students basic concepts and practices in the field of transportation planning, including 
the process and policy surrounding urban transportation planning. 
Catalog Description: Basic concepts and practices in the field of transportation planning, including the process 
and policy surrounding urban transportation planning, characteristics of urban travel, air quality, noise, energy, 
land use, the elements of decision making, data management and diagnosis, demand and supply analysis, project 
evaluation and implementation. A transportation demand management study constitutes a major part of the 
course. (2.0 ED/1.0 ES) Lec. 3. Prerequisites & Notes: CIE 225. Credits: 3 
Expected Course-Specific Outcomes: 
The student will: 
 1. understand basic terminology used by transportation planners 
 2. have a basic understanding of some of the history behind today’s transportation planning 
 3.  understand how automobile traffic influences safety, mobility, environment, and financing 
 4.  understand how trips are generated, distributed and assigned to modes and routes   
 5. acquire an understanding of professional and ethical responsibility 
 6. acquire a knowledge of contemporary transportation-planning issues 
 7.  acquire an understanding of the impact of engineering solutions in a global and societal context 
 8. acquire an ability to identify, formulate, and solve transportation planning problems 
 9.  acquire an ability to design and conduct experiments, as well as to analyze and interpret data 
     10. acquire an ability to design a system, component, or process to meet desired needs, such as maximum 
allowed noise levels. 
General Information: 
1.  Good attendance is encouraged since the tests will include questions not only on the textbook but also 
additional material covered during the lectures. Quizzes may appear without any notice! 
2 A project will be completed.  The project will be worked on in groups of 2 - 4 students.  The objective 
of the project will be decided on together with the students.  It is recommended that this year, the 
projects should deal with issues relating to the City of Bangor’s next comprehensive plan (due during 
2010).  Should Bangor’s transportation systems be ‘nudged’ in a specific direction or should market-
forces rule?  What about bicycling? Public transportation?  Connections to other regions, etc.  But the 
project could also be to do a Travel Demand Management Study for a smaller urbanized area; or to look 
at noise concerns in…. or….  The work should typically include detailed structuring and scheduling of 
the study, formulation of hypotheses to be tested, observational field studies, making up and administer-
ing interviews and questionnaires, the writing of a report, and presentations of the findings to the class 
and possibly to invited professionals.  Survey forms must be discussed in class before they are admi-
nistered.  If a project includes a survey, or other direct interaction with people, make sure that: 
  a) You approach people over the age of 18 only 
  b) You identify the project to participants as a class assignment, not as university research 
  c)  You inform participants that data will be destroyed after their assignment or class project is completed 
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  d) The data does not contain any personal, identifying information whenever possible 
  e) The  project includes informed consent language.  For an on-line survey, this would be the first page of 
the survey or in the email post.   Make sure the participant is told: 
     - about the identity of the investigating student(s) (introduce yourself) 
    - that this is a class project.  (Give a little information, e.g., This is for my … class, I am trying to study…) 
- what they will be asked to do (“I would like to ask you some questions about why you ….  If there are 
any questions you don’t want to answer, it is fine to skip them.”) 
- how long the interview, survey, etc., may take to complete 
- what will happen to the information collected (“The information will be used to write my paper for the 
class, and I may give a presentation in class.  All of my notes, surveys, etc., will be destroyed …”) 
- if they will be identified. Examples:  “I will not write your name on my notes”; “Do not write your 
name on the survey;” “I will not use your name in my paper.” 
- the student’s and instructor’s contact information if they have any questions (provide phone num-
ber/email). 
  f) Protected Populations. Do not approach these groups.  Examples include, but are not limited to: Child-
ren/Minors (under the age of 18), prisoners (now includes non-publicly available secondary data), preg-
nant women, fetuses and products of labor and delivery, people with diminished capacity to give con-
sent, mentally or physically challenged individuals. 
  g) Sensitive Information that you cannot include – Examples include, but are not limited to: Information 
relating to an individual’s psychological well being or mental health; information relating to sexual atti-
tudes, preferences, or practices;  information relating to the use of alcohol or drugs; information relating 
to illegal behavior, information that if released could reasonably place the individual at risk of criminal 
or civil liability or be damaging to the individual’s financial standing, employability, or reputation; in-
formation that would normally be recorded in a patient’s medical record and the disclosure could rea-
sonably lead to discrimination, stigmatization, etc. 
3. Homework problems will be assigned but not collected or graded.  Test questions will sometimes be simi-
lar to assigned homework. 
4. Students are expected to be present during times assigned to the project and for all tests.  Make-up tests 
will be given only for authorized medical reasons. 
5. All computations and steps should be shown for all exams, whenever requested. Some tests may be of 
multiple-choice type. 
6. Civil Engineering students must adhere to the University of Maine Conduct Code.  Each student is ex-
pected to work independently on all exams, including take home exams.  Students may neither give nor 
receive assistance on examinations.  All written material, including term papers, reports, etc., must be the 
student's original work.  The bounds of original work and the degree of collaboration that will be allowed 
in this class will be established by the professor.  The work(s) of others may only be used with proper ref-
erence or acknowledgement.  Failure to adhere to this policy can result in the receipt of a failing grade, 
suspension or dismissal from the University.  Group interaction is generally necessary for laboratory data 
gathering and is encouraged but not necessary for data reduction. 
7 Accommodations for students with disabilities:  If you have a disability for which you may be requesting 
an accommodation, please contact either me or Ann Smith, Coordinator of Services for Students with 
Disabilities (Onward Building, 581-2319), as early as possible in the term. 
8. No tuition refund will be allowed if course dropped later than second week of classes-unless very extraor-
dinarily extenuating circumstances exist. 
9. Examinations: 
             Test 1 15% Quizzes 2% each Main Project 20% 
Test 2 15% Mini-project 1/2 5% Final exam 20% 
Test 3 15% Newspaper 3%   
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10. Grades: 90% and above  A 
   87.5-89.99%   A- 
   85-87.49%   B+ 
   80-84.99%   B 
   77.5-79.99%   B- 
   75-77.49%   C+ 
70-74.99%    C 
67.5-69.99%   C- 
65-67.49%   D+ 
60-64.99%   D 
Below 60%   E 
  
 
11. SCHEDULE  CIE 424: Tuesdays and Thursdays 8:00-9:15 in 130 Barrows Hall 
 
Jan. 12 Introduction and consensus exercise   
 14 Rethinking Urban Sprawl. Andres Duane, 
video.   
 19 Chapter 1 & notes. Mini-project: Travel 
Diary Mini-project 1 and 2 assigned 
 21 Continued Chapter 1 and notes 
 26 Transportation Planning and Decision-
Making, Question 7 (page 83) assigned + 
Mini-project assignment: Review BDN 
for two weeks ‘environment’ and ‘trans-
portation’ 
 28 Transportation Systems, Chapter 3. 
Project. Finalizing overall objectives and 
group belongings.   
Feb 2 Air Quality 
 4 Noise (Chapters 3, 7). Assignment 
 9 Energy-Land use (Chapters 3, 7) 
 11 Characteristics of Urban Travel 
 16 Safety, Travel costs, Chapter 3 
 18 Test 1 
 23 Data Management and Use, Chapter 4. 
Question 4 (page 239) assigned  
 25 Demand Analysis, Chapter 5 and Project-
presentation of group objectives, draft 
outlines and discussion on surveying 
techniques 
Mar 16 Trend analysis, Elasticity models Home-
work.  Chapter 5. 
 18 Minimum path—equilibrium Assign-
ment. 
 23 Gravity model, Chapter 5, Modified 
Question 6 (page 322) take-home quiz 
assignment 
 25 Logit model, Chapter 5. Questions 8 & 9 
(page 324) assigned 
 30 Test 2 
Apr 1 Urban Activity Systems.  Chapter 6. 
Question 5 (page 377) assigned 
 6 continued Chapter 6 
 8 Supply Analysis (fundamental eq.), 
Chapter 7 Time-distance diagrams, 
queuing theory. Questions 1, 2, and 3 
(page 474) assigned Transit/walking, 
Question 5 (page 476) assigned 
 13 Cost models, Chapter 7 
 15 Transportation System and Project Eval-
uation, Chapter 8. Question 4 & 6 (page 
558) assigned 
 20 Program and Project Implementation, 
Chapter 9 
 22 Test 3 
 27 Project presentations 
 29 Traffic calming or SL. Class evaluation 
May 3-7Final Exam (open book) 
 
Note: The above schedule and procedures in this 
course are subject to change in the event 
of extenuating circumstances. In the event 
of disruption of normal classroom activi-
ties due to an H1N1 swine flu outbreak, 
the format for this course may be modified 
to enable completion of the course. In that 
event, you will be provided an addendum 
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Human Subject Payment Guidelines 
1. University of Maine researchers may provide cash (or cash equivalents [incentives], 
including gift cards, meal money, apparel, etc.) to human subjects if the protocol has been 
approved by the Institutional Review Board (IRB). 
2. It is the responsibil ity of the researcher (not the IRB, Office of Research Administrat ion, 
or the Office of the Vice President for Research and Dean of the Graduate School) to 
make appropriate funding arrangements. 
3. If the approved I RB protocol assures the confidentiality of human subjects, researchers 
will maintain the following data* , as speci fied in the I RB-approved protocol, in a secure 
project file: 
• Subject name 
• Subject address 
• Date the payment was provided 
• Value or amount of the payment 
• Form of the payment 
• Name of researcher providing the payment 
• Peoplesoft chartfield combination 
• UMS employee status of the subject (UMS employee or non-employee). 
4. If the University of Maine is subject to an audit, researchers may be required to provide 
auditors access to confidential data. 
5. If the value of a one-time payment exceeds $75.00, subject data must be reported to 
other offices within the University of Maine and University of Maine System, as follows: 
• If the human subject is an employee of the University of Maine, the researcher must 
........... ,,.....+ ......... ,.-.,,-h ......... , , ....... ,,.. ........ .- .,.,..., +h .... r-. ......................... ............. ,,..,fu , , ................ n .... ,..,,... ,,,...,.. .... ,.. T h .... r-. ........ .... ....................... ... 
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of Human Resources will determine whether the value of the reported incentive 
needs to be added to the employee's gross wages, and whether the payment w ill be 
subject to taxation and withholding. 
• If the human subject is not an employee of the University of Maine, the researcher 
shall report any such payments to Michael Noblet in the Department of Purchasing. 
The researcher will work with t he Department of Purchasing to comply with IRS 
regulations that require the University of Ma'ine System to issue a Form 1099 when 
cumulative payments to a non-employee reach $600 in a calendar year. 
* If the subjects are minors, contact the IRB office for furt her guidance. 
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Information About Oral History Activities 
Recently, representatives from the Office of Human Research Protection (OHRP) and the 
Oral History Association engaged in a dialog about whether oral history interviewing 
activit ies meet the OHRP's definition of research. According to OHRP. oral history 
interviewing activities, in general, are not designed to contribute to generalizable 
knowledge and do not meet the definition of research offered by the Department of 
Health and Human Services. The Univers ity of Maine's IRB recognizes this and concurs 
that the majority of oral history interviewing projects probably do not constitute research. 
However, some ora l history interviewing projects may meet the definition of research. 
Thus, it would be difficult and misleading to adopt a policy for any type of activities by any 
department, group, or individuals under a particular heading (e.g., oral history 
interviewing projects) that unequivocally states that the activity does not meet the 
definit ion of research and does not require review by the IRB. The IRB realizes that 
individuals may construe our position on this issue as ambiguous. The IRB, however, 
needs to make decisions about projects on a case by case basis. Thus, we cannot adopt a 
policy that directly states that all oral history interviewing activities are not considered 
research. We offer the following informat ion that might be helpful in determining when a 
project is considered to be or not to be research. 
To assist individuals in determining when/ if oral history act ivit ies require human subjects 
review. we have provided the fo llowing information from Michael Carome (OHRP). (This 
information represents a response to Northern Il li nois University's request for 
clarification regarding oral history projects.) 
The University of Maine's IRB found this information to be helpful. As University of Maine 
employees, students, and agents read this and see statements such as, "Unless such 
research is exempt under HHS regulations at 45 CFR 46.1 01 (b) ... " remember that it is 
UMaine policy (as it is at most institutions) that someone OTHER than the investigator 
must determine if a project fits one of the six categories judged exempt from further 
review. "Exempt" does not mean a review is NOT required. 
More formal guidance is expected from OHRP, so we will post addi tional information 
when/ if it is avai lable. 
Listed below are the examples provided to assist in determining when a review might be 
required. 
"As you are aware, representatives of oral history organizations earlier this year asked 
OHRP to review a policy statement that they had drafted regarding the relationship 
between research (as defined by the Department of Health and Human Services (HHS) 
regulations at 45 CFR 46.102(d)) and oral history activit ies. They also asked whether OHRP 
agreed with the content of their draft policy. 
OHRP responded to the oral histor ians w ith a letter stating OHRP's concurrence with the 
draft policy statement that oral history activit ies in general do not involve research as 
defined by the HHS regulations and providing some suggested edits. I have attached a pdf 
file containing a copy of OHRP's letter below. Please note that the inclusion of t he words 
"in general" in OHRP's response means that certain human subjects research activities 
may include oral history activities, and such research activities should be reviewed by an 
institutional review board (IRB) unless the research is exempt under HHS regulations at 45 
CFR 46.101 (b). I 
Indeed, in its September 22 letter, OHRP noted that on occasion, investigators conducting 
human subjects research as defined by the HHS regulations may use oral history 
interviewing procedures. Unless such research is exempt under HHS regulations at 45 CFR 
46.101(b), IRB review would be required if the research is conducted or supported by HHS 
or conducted under an applicable OHRP-approved assurance. 
History 
Issues regarding oral history and human subjects research date back to the National 
Commission and most recently emerged with NBAC, NHRPAC. and a letter from oral 
historians to OHRP. 
The Regulatory Definition of Research 
A decision whether oral history or other activit ies solely consisting of open ended 
qualitative type interviews are subject to the policies and regulations outlined in an 
institution's FWA and HHS regulations for the protection of human research subjects (45 
CFR 46) is based on the prospective intent of the investigator and the definit ion of 
"research" under HHS regulations at 45 CFR 46.102(d): "a systematic investigation, 
including research development, testing and evaluation, designed to develop or 
contribute to generalizable knowledge." 
Specifically, for the purposes of Olff discussion, the evaluation of such activities hinges 
upon whether the person is engaged in the creat ion of "generalizable knowledge" that is, 
whether the activity represents a systematic invest igation in which the person engaged in 
such activit ies intends to develop or contr ibute to generalizable knowledge. However, 45 
CFR 46 does not provide a definit ion of "general izable knowledge". Oral history activities, 
as described to OHRP by the oral history representatives, in general are designed to 
create a record of specific histor ical events and, as such, are not intended to contribute to 
generalizable knowledge. 
f 
General principles for evaluating Oral History type activities 
1. Oral history activities, such as open ended in terviews, that ONLY document a 
spec ific historical event or the experiences of ind ividuals w ithout an intent to draw 
conclusions or generalize findings would NOT constitute "research" as defined by 
HHS regulations 45 CFR part 46. 
o Exam ple: An oral history video recording of interviews with holocaust survivors 
is created for viewing in the Holocaust Museum. The ueation of the video tape 
does NOT intend to draw conclus ions, inform policy, or generalize find ings. The 
sole purpose is to create a historical record of specific personal events and 
experiences related to the Ho loca ust and provide a venue fo r Holocaust 
survivors to te ll their stories. 
2. Systematic investigations involving open-ended interviews that are designed to 
develop or contribute to generalizable knowledge (e.g. , designed to draw 
conclusions, inform policy, or generalize find ings) WOULD constitute "research" as 
defined by HHS regu lations at 45 CFR part 46. 
o Exam ple: An open ended interview of surviving Gulf War veterans to document 
their experiences and to draw conclusions about their experiences, inform 
policy, or generalize findings. 
3. Oral historians and quali tative investigators may want to create arch ives for the 
purpose of providing a resource for others to do research. Since the intent of the 
archive is to create a repository of informat ion for other investigators to conduct 
research as defined by 45 CFR part 46, t he creation of such an archive WOULD 
constitute research under 45 CFR pa rt 46. 
o Example: Open ended interviews are conducted with surviving Negro League 
Baseball players in order to create an archive for future research. The creation 
of such an archive would constitute research under 45 CFR part 46 since the 
intent is to collect data for future research. 
An inst itution shou ld perform an initial two step evaluation prior to deciding whether an 
activity constitutes human subject research: 
• determine whether the activity constitutes "research" as defined by 45 CFR 
46.1 02( d); and 
• determine whether the "research" inc ludes human subjects as defined by 45 CFR 
46.102(f). 
In summary, the August 26, 2003 Policy Statement attached to OHRP's September 22, 
2003 letter was not drafted by OHRP, does not constitute OHRP gu idance, an d the 
character izations of oral history activit ies in the th ird paragraph of the Policy Statement 
alone do not provide suffic ient basis for OHRP's determination that oral history activit ies 
in general do not involve research as defined by HHS regulations at 45 CFR part 46. Other 
activities involving open-ended interview that have similar characterist ics can involve 
research as defined by the HHS regu lations when t he activities are part of a systematic 
investigation designed to develop or cont ribute to genera li zable knowledge." 
We hope that the above informat ion may be helpful to individuals who engage in oral 
history interviewing activities. If an ind ividual has any question as to whether his or her 
project could be considered research, please contact the IRB office. 
D @) 
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 Except where specifically waived or altered by the IRB under Section I.K.3-4 of the 
University of Maine’s Policies and Procedures for the Protection of Human Subjects of 
Research, all human subjects research will require written informed consent. For projects 
exempt from further review, documentation (signature) of informed consent is not required, 
but the same basic elements of an informed consent should be applied. The following two 
paragraphs were taken from the Office for Human Research Protections (NIH) website on 
the protection of human subjects of research. 
 
 “Informed consent is a process, not just a form. Information must be presented to 
enable persons to voluntarily decide whether or not to participate as a research subject. It is 
a fundamental mechanism to ensure respect for persons through provision of thoughtful 
consent for a voluntary act. The procedures used in obtaining informed consent should be 
designed to educate the subject population in terms that they can understand. Therefore, 
informed consent language and its documentation (especially explanation of the study's 
purpose, duration, experimental procedures, alternatives, risks, and benefits) must be 
written in "lay language", (i.e. understandable to the people being asked to participate). The 
written presentation of information is used to document the basis for consent and for the 
subjects' future reference. The consent document should be revised when deficiencies are 
noted or when additional information will improve the consent process.”  
 
“Use of the first person (e.g., "I understand that ...") can be interpreted as 
suggestive, may be relied upon as a substitute for sufficient factual information, and can 
constitute coercive influence over a subject. Use of scientific jargon and legalese is not 




NOTE: For studies requiring continuing review, approval information (with expiration 
date) will be added to the approved informed consent document; that version will be 
provided to the researcher and must be used in obtaining consent. This procedure helps 
ensure that only the current, IRB-approved informed consent document is presented to 
subjects and serves as a reminder to the investigator of the need for continuing review. 
 
 2 
Informed Consent Checklist 
 
Include these items in the form: (NOTE: The form should be written at no higher than 
an eighth grade reading level. FOLLOW THE SAMPLES [INCLUDING 
HEADINGS] found on the IRB website.) 
 
1)       With the Revised Common Rule that went in effect in January 2019 studies  
with longer consent forms (more than 1 page) or Federally funded studies a concise 
summary is required. 
The concise summary is meant to be brief. The purpose of the summary is for the 
participant to decide why he/she may want to participate but should also include 
information on why he/she may not want to participate in the study (for example a 
huge time commitment or other risks). The summary should not include all 
foreseeable risks but the risks that would be most likely or most severe to the 
participant. 
 
The summary should include the following 5 elements: 
1) A statement that the project is research and that it is voluntary. 
2) A summary of the research (purpose, overview of procedures etc.) 
3) Any foreseeable risks or discomforts 
4) Any expected benefits to participants (if applicable) 
5) If applicable, alternative procedures to course of treatment 
  
 
2)  A statement that the potential subject is being asked to participate in a research 
project. Include the name of the person who is conducting the research and his/her 
title/department. If the principal investigator is a student, the faculty sponsor should 
also be identified with his/her affiliation. 
  
3) An explanation of the purpose of the research. 
 
4) A description of the procedures to be followed. Include sample questions from any 
instruments that may be used (not required for mail/internet surveys where the 
questionnaire is enclosed/follows the consent). 
 
5) An estimate of the amount of time it may take to participate. 
 
6) A risk statement (reasonably foreseeable risks or discomforts). Examples: in some 
studies, answering questions may cause people to become uncomfortable; for 
studies involving standard blood draws, the possibility of bruising exists. For studies 
that have no foreseeable risks, examples include, “There is no more risk to you in 
participating than in everyday living,” or “Except for your time and inconvenience, 
there are no risks to you from participating in this study.” Do not state that there are 
no risks – all studies have risks even if only time and inconvenience! Do not state 
“You could become uncomfortable answering questions and except for your time 
and inconvenience, there are no risks to you from participating.” If someone could 
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become uncomfortable answering questions, the risk is more than time and 
inconvenience – it’s one or the other. 
 
7) A description of any potential benefits to the subject or to others that may 
reasonably be expected from the research. It is possible that a study will have no 
direct benefit to the participant! (e.g., “While this study will have no direct benefit 
to you, this research will help us learn more about…”). There should be two 
statements – benefit of the research to the participant and benefit of the research in 
general. 
 
8) A description of compensation, if applicable. List any compensation for 
participation (money, course credit, etc.). Also indicate how compensation will be 
handled if a participant withdraws from the study. Do not include if there is no 
compensation. 
  
NOTE: If the compensation exceeds $75 in value, the following language should be 
added to the Compensation Section (See Human Subjects Payment Guidelines for 
additional information.). 
 
Basic information (your name and address, date of payment, value of payment, my 
name as researcher) will be given to a University office for tax reasons: 
- Employee of UMaine (including student employee): Information will 
be sent to the Human Resources Department. The value of the 
compensation may be added as wages and subject to taxation.  
- Non Employee: Information will be sent to the Purchasing 
Department. If you receive $600+ during a calendar year (January 1 
– December 31) from participating in UMaine research projects, 
Form 1099 will be generated and mailed to you. If you do not receive 
that much money, information will be destroyed at the end of the 
calendar year (i.e., December 31st). 
 
9) For treatment studies only, include a description of appropriate alternative 
procedures or courses of treatment that might be advantageous to the subjects. 
 
10) A description of confidentiality. Will names be associated with the data? Will the 
data be coded and linked to a master list of names (key)? Who will have access to 
the data? Where will the data be stored (e.g., locked office, password protected 
computer)? If you are keeping the key electronically, you need to encrypt it (see 
guidelines on encryption. Explain the retention of the data (including any audio, 
video, or film recordings): a) if coded, when will the key be destroyed? and b) How 
long will the data be kept (e.g., destroyed by date, kept indefinitely, etc.)? Is the 
study anonymous? Don’t confuse anonymity and confidentiality. If names are 
connected to data (even if you have coded the data), you can’t tell participants that 
their identity will remain anonymous! You can only guarantee anonymity if no one, 
including you as the researcher, can identify participants. If participants will be 
involved in a group interview, you can assure them that you will keep their 
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responses confidential and will ask other participants to do the same, but you cannot 
absolutely guarantee that other group members will keep their responses 
confidential. Use dates (month/year) for destroying keys, data, etc., if applicable. Do 
not simply say “upon completion” or “when all data have been collected.” 
Participants don’t know when that will be! 
 
11) A statement that participation is voluntary. If subjects choose to participate, they 
may stop at any time or skip any questions they do not wish to answer. If the study 
involves compensation such as payment or course credit, make sure it is clear what 
happens if they drop out (e.g., do they have to complete the entire study to receive 
the compensation, is there partial compensation for completing part of the study, or 
do they receive the compensation regardless of the length of participation (e.g., “you 
may stop at any time without loss of research credit”). 
 
For an anonymous mail survey, include the statement, “return of the questionnaire 
implies consent to participate” (if electronic, use “submission”). 
 
12) An explanation of who to contact for answers to questions about the research 
(include name, phone, e-mail). If a student is the principal investigator, also include 
the same information for the faculty sponsor. Also include a statement directing 
people to the Office of Research Compliance, University of Maine, 207-581-2657, 
umric@maine.edu, if they have questions about their rights as a research participant. 
 
13) A statement that their signature (if not exempt) indicates they have read and 
understand the information and agree to participate. Indicate that they will receive a 
copy of the form. The investigator should NOT sign the consent form – doing so 





• Use familiar words, e.g., “cholesterol” instead of “blood lipids.”  
• Avoid using scientific, medical, or legal terms – if you must use them, define them. 
• Avoid abbreviations or acronyms. 
• Use bullets if procedures are lengthy. 
• For ease of reading, have “white space” on the form.  
• Know your target population. For example, if you are studying the elderly, use a 
larger font size.  
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How to Request a Modification to a Previously 
Approved Study 
Follow these simple steps to modify an existing study: 
1. Using a different color font (or track changes), edit all applicable sections of the 
previously approved application (make sure you are using the final approved copy). 
Make sure new recruitment materials (emails/flyers), new measures, new consent 
forms, etc., are included, as applicable. Note that changes in the procedure often 
need to be reflected in the consent (e.g., adding measures may increase the time 
needed to complete the study). This edited application should be ONE document 
(Word only; no PDF). 
2. Please note that if you have already collected data but now want to change 
methods/measures going forward, you need to retain all of your or iginal approved 
mater ials in the application and then add the modifi cation describing what you want 
to do differently in the future. 
You should clear ly designate the original procedures vs. the new procedures. The 
application needs to reflect the entirety of the project. 
3. Send an email to umric@maine.edu requesting the modification. The email should 
reference the tit le and number of the approved application, and briefly describe the 
modification. Attach the updated application and send. 
When is a modification really a new study? 
If the proposed modifi cation includes changes to t wo or more of the following criteria, the 
IRB would consider this to be a new study and the investigator would need to submit a 
new study application. 
1. Study population 
2. Study procedures 
3. Study purpose 
Change in Personnel 
If you simply need to update personnel on an approved study, you do not need to edit 
the approved application. An email referencing the study t it le and number along with 
name of person(s) to be added, years of human subjects research experience, ro le on the 
project, and email is sufficient. If the CITI tra ining was not completed through UMaine 
please also provide the training certificate. 
Some personnel changes may also require a change to other sections of the application 
such as the consent document, and recruitment mater ials. In such cases, the application 
should be modified to include these changes and submitted as a modification for review. 
Please contact the IRB office with any questions. 
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Internal Institutional Data Collections 
Internal institutional data collections are typically not considered research* and, 
therefore, review by the Institutional Review Board for the Protection of Human Subjects 
(IRB) is not required. Internal data collections are most often used to change/improve a 
campus service. Examples include: 
1. Surveys of dining preferences 
2. Evaluations of student satisfaction for accred itation reports 
3. Exit surveys for graduates or employees 
4. Surveys to determine residence hall programming needs 
If an internal institutional data collection follows the examples and purpose stated above 
(i.e., to change/improve a campus service), IRB review is not required. If you have any 
questions on whether a proposed internal institutional data collection requires IRB 
review, please contact the IRS Office. 
*Research is de fined a s: "a systematic investigation, induding <ese.arch deve lopment, testing and evaluation, designed 
,o develop or contribute to generalizable knowledge." [45 CFR 46, 1 02(d)) Generalizable knowledge is information 
which has the potential to be expanded from the isolated circum stances in which it is acquired to any broader context. 
D @) 
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Reactivating a Closed Study 
Re-opening a closed study is handled on a case by case basis by the IRS. You can request 
reactivating a closed study up to 12 months after the study was closed. After this time, a 
new application submission will be required. 
To re-open the study the Pl must submit the following: 
1. The reason why the study was closed and the reason why it needs to be re-opened. 
2. Confirmation that no participants were enrolled and no data collection occurred 
while the study was closed and that this is the continuation of the same study. 
3. If applicable, a modification with any requested changed to the application, 
personnel, etc. since t he application was last approved. 
4. An updated continuing review (if applicable) w ill need to be submitted. 




This is a template for a handout to be used for studies on sensitive topics where referrals are required. Edit as 
necessary and delete this row containing these instructions. Be sure to provide names of organizations (with 
contact information and hours of operation) that are relevant to your specific study. All contact information must 
be accurate and up-to-date. National directories may be appropriate for online studies where the locations of 




Available for UMaine Faculty, Staff, and Students 
Counseling Center 
Cutler Health Building (Gannet Hall side) 
(FREE to UMaine students) 







Weekdays 8:00 am-4:30 pm  
After business hours, call UMaine 
Police, 581-4040 or 911 
Psychological Services Center 
330 Corbett Hall 






Weekdays 8:00 am – 4:30 pm 
 
COMMUNITY RESOURCES 
Available to Anyone 
Community Health & Counseling Services 
42 Cedar Street 
Bangor, ME  04401 










Weekdays 8:00 am-5:00 pm 
 
Maine Crisis Hotline 








7 days/week 24 hours 
Psychological Services Center 
330 Corbett Hall 







Weekdays 8:00 am – 4:30 pm 
Contact Your Primary Care Provider 







Behavioral Health Services Locator https://findtreatment.samhsa.gov/ 
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Considerations When Assessing Sex and Gender in 
Research 
The IRB at the University of Maine encourages researchers to be sensitive to and inclusive 
of differences when collecting data about identities of participants. 
Definitions 
Gender/Gender Identity is a person's internal held sense of their gender, regard less of 
biology. 
Sex refers to biological differences between males and females, such as the genitalia and 
genetic d ifferences. Sex is assigned at birth. 
Sexual Orientation is a t erm used to describe one's pattern of emotional, romantic 
and/or sexual attraction. 
Sample Questions 
Below are sample questions and response options for gender identity, sex, and sexual 
or ientation. 
1. What is your current gender identity? (Check all that apply.) 
• Male 
• Female 
• Transgender female I t rans woman (or Male-to-Female (MTF) transgender, 
t ranssexual, or on the trans female spectrum) 
• Transgender male I trans man (or Female-to-Male (FTM) t ransgender, transsexual, or 
on the trans male spectrum) 
• Non-binary, genderqueer, or genderfluid 
• Gender identity not listed: 
• Prefer not to reply 




• Not Listed: 
• Prefer not to reply 





• Not listed: 
• Prefer not to reply 
4. [If investigators w ill refer to participants directly it is respectful to ask which pronouns 
they should use]: 
What pronouns would you like study staff to use when referr ing to you? (The Pis 
may want to consider introducing themselves by name and pronouns to 




o Other (please specify): 
Tips for Researchers 
• Use the term sex when reporting biological factors and gender when reporting 
gender identity, psychosocial or cultural factors. 
• Consider if it is relevant to the study to include questions regarding sexual health 
history and/or sexual or ientation. 
• Sex, gender identity, and sexual orientation are both sensitive and personal 
character istics. Therefore, it is important to protect this informat ion, especially when 
recorded as identifiable. Investigators must ensure that research subjects provide 
this information in a locat ion where they are comfortable and that ensures their 
privacy. 
• All study documents (including surveys) should use gender-neutral language, 
avoiding gendered terms (e.g., mailman, chairman) and gendered pronouns (he, 
she, he/she). Gendered terms should be replaced with non-gendered versions (e.g., 
mail carrier instead of mailman or chairperson instead of chairman). Sentences 
using gendered pronouns should ei ther use gender-neutral pronouns (e.g., singular 
they as in "Each subject will receive their gift card upon completing the study.") or be 
reworded entirely to avoid such pronoun use (e.g., "Subjects will receive their gift 
card upon completing the study."). 
Avoid presuming roles whenever possible. For example say "spouse/partner" 
instead of "husband/wife". 
f 
Incorporate gender neutral diagrams in research materials. 
• Do not assume pronouns w hen interacting w ith a subject until they identify a 
preference. 
• Train your research team members to increase t heir comfort level in asking and 
answering sensit ive questions about gender and sexual orientation from subjects. 
The FenwaY. Institute is a good source for tra ining materials. 
References and Resources 
ReP-orting Sex, Gender, or Both in Clinical Research 
Guidelines and tips for collecting_patient data on sexual orientation and gender identity 
Sex and Gender E!;]uitY. in Research: rationale for the SAGER guidelines and recommended 
use 
Canadian Institutes of Health Research Online Training Module 
Reviewer Guidance to Evaluate Sex as a Biologica l Variable (NIH) 
Inclusion of sex and gender in biomedical research: SurveY. of clinica l research 12ro12osed 
at the Universify. of PennsY.lvania 
UHSRC Guidance: Use of Gender Inclusive Languag~ 
Sex and Gender Research Considerations (Tufts) 
!Dim 
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What is GDPR? 
The General Data Protection Regulation (GDPR) is a European law that went into effect 
May 2, 2018 and establishes protections for privacy and security of "personal data" about 
individuals in t he European Economic Area (EEA). 
Please note that GDPR considers "coded date" to be "personal data" even where one lacks 
access to the key-code/coding system required to link data to an individual data subject. 
This is in contrast to US regulation protecting human subjects. 
What countries are part of the EEA? 
Austria, Belgium, Bulgar ia, Croatia, Republic of Cyp rus, Czech Republic, Denmark, Estonia, 
Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, 
Lithuania, Luxembourg, Malta, Nether lands, Norway, Poland, Portugal, Romania, Slovakia, 
Slovenia, Spain, Sweden, and the UK. 
Please note that the participant does not need to be an EEA resident for the GDPR to 
apply. 
Under GDPR what is considered "Person al Data"? 
Information t hat relates to an identifi ed person. Examples are: name, email, IP address or 
cookie number, personal character istics (this also includes photographs). 
Additional protections are given to sensitive personal information such as race, political 
opinions, religious bel iefs, genetic data etc. 
Tips on how to comply with GDPR? 
If the study can be completed using de-identified data that would be the best option. If 
you need to collect personal data collect the minimum amount of demographic/personal 
data n ec essa ry. 
Be aware that online survey sites often collect IP addresses by defau lt so make sure you 
set up your survey to collect only the information you need for the study. 
If you are collecting identifiable data you need to have a plan on how you will remove the 
data if the participant requests this. 
How to ensure consent process complies with GDPR? 
The consent process needs to be active so for example, in an electronic survey the 
part icipant should click to consent to proceed with the survey. It must be an affirmative 
action. 
You must maintain consent records for the participants. For example, if the participant is 
giving verbal consent you must maintain a log with t he subject name or ID and the date 
and time consent was provided. 
Consent forms must contain the following information: 
• Who is collecting the information? (must include contact information of person(s) 
collecting the information) 
• What information is being collected? 
• How is the information collected? 
• How wil l the information be used? 
• How will information be stored and for how long? 
• Who w ill data be shared with? 
• How does a part icipant withdraw from the study? (The participant needs to be 
informed of their r ights to request access, erasure, and/or object to the processing 
of the data.) 
Additional information about GDPR 
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Zoom Guidance for IRB Studies 
When using Zoom technology, at a minimum, please follow the guidelines outlined below: 
1. Participants should be reminded to protect their pr ivacy by completing activities 
in a private and quiet space, to ensure conversations are not overheard and ensure 
that t here are minimal interrupt ions. 
2. Researcher should establish ground rules with participants; t his could include not 
taking screen shots, not recording the session etc. 
3. Passwords should be used for Zoom meet ings with research participants. 
4. Participants should be told how and where Zoom record ings are saved. 
To disable Cloud Recordings (this is the preferred setting for recordings) 
follow these steps: 
■ In the "Meeting Settings" select the "Recording'' tab. 
■ Turn ON the "Record on the local computer" option. 
■ Turn OFF the "Cloud Recording" op tion. 
■ This enables you to save both audio and video fil es of Zoom recordings to 
your computer. 
If using Cloud Recordings: In some cases, it may be necessary for you to use 
Cloud Recordings in order to utilize Zoom's "Audio Transcr ipt'' feature. If you 
would like to create Cloud Recordings, participants must provide their consent. 
You must include t he fo llowing information in t he "Confidentiality" section of 
the consent form: 
■ Tell participants that recordings w ill be stored on the Zoom Cloud and tell 
them wI1en those recordings w ill be deleted (recordings should be 
deleted as soon as possible from t he Zoom Cloud). 
■ Tell part icipants that the record ings are subject to Zoom's P-rivacy_P-olicy. 
You have flexibili ty on how to present Zoom information to participants. 
Reminders can be part of consent form or recruitment script, or at the 
beginning of the Zoom session. 
NOTE: The free and regular paid versions of Zoom are not HIPAA compliant and 
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Federal and State Regulations & Guidance Materials 
OHRP - Office for Human Research Protections 
• 45 CFR 46 - Federal Regulations for the Protection of Human Subject - applies to 
ALL human subjects studies 
NIH - National Institutes of Health 
• Education Re~uirement - FAQs regarding the NIH Education Requirement 
• Special Topics: 
o Certificates of Confidentiali ty, 
o Data Sharing 
o Inclusion Policies for Research Involving Human Subjects 
o Single IRB 
NSF - National Science Foundation 
• Human Subjects - NSF Policy for human subjects research (HSR) 
• Behavioral and Social Science Research - NSIF interpretation of Common Rule and 
Behavioral and Social Science Research 
FDA - Food and Drug Administration 
Studies using investigational drugs, devices or biologics 
• 21 CFR 50 - FDA Regulations for Protection o f Human Subjects 
• 21 CFR 56 - FDA Regulations for Institutional Review Boards 
• Guidance for interP-reting 21 CFR 50 and 56 
• ComP-arison of FDA and HHS Human Subject Regulations 
VHA - Veterans Health Administration 
• ORO - Office of Research Oversight 
HIPPA Regulations 
• 45 CFR 160, 162 and 164 
DoD - Department of Defense 
• DoD Directives 
• DoD Instruction 
General 
• The Belmont ReP-Ort 
• The Nuremberg Code 
• Declaration of Helsinki ("The World Medical Association has developed the 
Declaration of Helsinki as a statement of ethica l principles to provide guidance to 
physicians and other part icipants in medical research involving human subjects.") 
• The Common Rule - Federal Policy for the Protection of Human Subjects 
Human Subjects 
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Required Training for the Protection of Human 
Subjects 
ALL personnel named in an existing or new "Application for Approval of Research with 
Human Subjects" must complete the Collaborative Institutional Training Init iative (CITI) 
web-based training on the protection of human subjects (this includes faculty sponsors 
on student studies). 
Instructions for CITI Training_{PDF) 
The CITI training is valid for four years from the date of completion. After four years, the 
"refresher" modules wil l need to be completed (you will receive a reminder from CITI). 
It is estimated that the training will take 1 hour. Passing score for quizzes is 80%. The 
components of the CITI training include: 
• Basic Courses in the Protection of Human Research Subjects. While there are four 
choices when enrolling, t he one that should be taken for the majority of UMaine 
faculty, sta ff, and students is Social and Behavioral Research Investigators. The 
Biomedical Research Investigators course can be selected for researchers that are 
conducting mostly biomedical research. 
• Electives: These electives do not appear until you have completed the main course. 
Select the area(s) pertaining to your research. You might need to take more than 
one, but you are required to take at least one. If none of the electives seems 
relevant to your research, we suggest Conflicts of Interest in Research Involving 
Human Subjects or Internet Research. 
o Confl icts of Interest in Research Involving Human Subjects 
o Internat ional Research 
o Internet Research 
Apply Student Resources 
f 
Nondiscrimination notice 
o Research with Children 
o Research w ith Prisoners 
o Research in Public Elementary and Secondary Schools (we recognize the 
heading states "Public," but please take this module if your research is 
conducted in private elementary/secon dary schools) 
ID1m 
[7!J D @) 
~ 
Clery Safety and Secunty Report COVID-19 health and safety guidance Emergency 
Univer$ity of Maine 
m 
 1 Last Updated 6/17/21 
Instructions to Access CITI Training 
Office of Research Compliance (ORC), University of Maine 
The Office of Research Compliance (ORC) delivers a variety of research training through the 
University of Maine System (UMS) subscription service to the Collaborative Institutional 
Training Initiative (CITI). These instructions guide you through the institution-specific CITI 
registration and enrollment processes. Further information about Research Compliance at the 
University of Maine and training requirements can be found on the ORC website. 
IMPORTANT NOTE: You are only required to complete the training(s) for your specific area(s) 
of research compliance. 
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I. Establish a CITI Account 
a. Please note: if you have previously set up a CITI account, please do NOT 
create another one. See Section II (Log into CITI as an Existing User) of this 
document for guidance. 
b. Go to CITI Program (https://about.citiprogram.org/) and click on the white 
“Register” button located in the upper right hand corner of the homepage. 
 
 
c. Search for ‘University of Maine System’ in the section titled ‘Select your 
Organizational Affiliation’ and click on it.  
i. Click the check boxes to agree to the CITI Terms of Service and Privacy 
Policy, and to agree that you are an affiliate of the University of 
Maine System. 
ii. Click the “Continue to SSO Login/Instructions” 
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d. Under “Associate your SSO account with a CITI Program account” click “I 
don’t have a CITI Program account and I need to create one.” 
i. Click the button that appears below labeled “Create A New CITI 
Program Account.”  
 
ii. This will automatically create an account for you using your UMaine 
SSO (Single Sign-On), the same login information used to log into the 
UMaine Portal, etc. You should also receive a confirmation email via 
your maine.edu email address with this information.  
II. Log into CITI as an Existing User 
a. To log into CITI once you have established your CITI account, go to CITI 
Program (https://about.citiprogram.org/) and click the blue “Log In” button 
located in the upper right hand corner of the homepage. 
 
 
b. On the login page, click the center option labeled “Log In Through My 
Organization.” 
c. On the list of organizations that appears, click on “University of Maine 
System” and you will be logged in using your UMaine SSO. 
d. NOTE: if you already had an account set up with CITI from another 
institution, you can affiliate that existing account with UMaine. See  
instructions from CITI on how to add/change your affiliated institution. 
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III. Enroll in CITI Courses 
a. New Users 
i. After you enroll, you will be brought to your “My Courses” page. 
Under “Institutional Courses,” click the button next to University of 
Maine System labeled “View Courses.” 
 
ii. You will be brought to the “Select Curriculum” page. Select any 
desired course(s) from the list. See section IV (Required Trainings) of 
this document for details on which specific trainings are required for 
each area of research. 
iii. Once you have made your selection(s), hit the “Submit” button at the 
bottom of the page (Note: you are able to sign up for additional 
courses later, after you have made this initial selection – see section 
III.b [Returning Users] of this documentfor instructions). 
b. Returning Users 
i. After logging into CITI as a returning user, you will be brought to the 
“My Courses” page. Click on the “View Courses” button next to the 
University of Maine System (as shown above under New Users).  
ii. On this page, you will see a list of all courses you are currently 
enrolled in and have previously completed. 
iii. To enroll in another course, scroll to the very bottom of the page to 
the section labeled “Learner Tools for University of Maine System.” 
Click the link for “Add a Course.” 
iv. You will be brought to the “Select Curriculum” page. Select any 
desired course(s) from the list. See section IV (Required Trainings) of 
this document for details on which specific trainings are required for 
each area of research compliance. 
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IV. Required Trainings 
PLEASE NOTE: You are only required to take the trainings for your specific area(s) of 
research compliance. 
If you are unsure of which trainings may be required for your research, please explore 
the resources available on the ORC website and reach out to the ORC for additional 
guidance as needed. 
Once you know which trainings are required for your research, find the relevant 
compliance area below and follow the instructions to sign up. See section III (Enroll in CITI 
Courses) of this document for instructions on how to enroll as a new or existing CITI users. 
a. Animal Care 
i. Visit Animal Care on the ORC website for guidance on when and for 
whom this training is required.  
ii. To enroll, on Question 6, select the required course “Working with 
the IACUC” (as shown below). In addition to the required “Working 
with the IACUC” course, we strongly recommend you take modules 
from these sections that apply to your research. 
 
List continues – see the CITI enrollment page for the full list of available modules. In 
addition to the required “Working with the IACUC” course, we strongly recommend 
you take modules from these sections that apply to your research. 
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b. Biosafety 
i. Visit Biosafety on the ORC website for guidance on when and for 
whom this training is required. 
ii. To enroll, on Question 7, select the following 4 courses: 
1. Introduction to Biosafety 
2. Basic Biosafety Training (Note: after enrollment, on My 
Courses page, the title will appear as “Training for 
Investigators, Staff and Students Handling Biohazards.”) 
3. Select Agents, Biosecurity and Bioterrorism 
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c. Conflict of Interest 
i. Visit Conflict of Interest on the ORC website for guidance on when 
and for whom this training is required. 
ii. To enroll, on Question 5, select “Conflicts of Interest (All OTHER 




d. Export Control 
i. Visit Export Control on the ORC website for guidance on when and for 
whom this training is required. 
ii. To enroll, on Question 8, select “CITI Export Controls.” (Note: after 
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e. Human Subjects 
i. Visit Human Subjects on the ORC website for guidance on when and 
for whom this training is required. 
ii. On Question 1, select one learner group based on your role and the 
research you will be conducting. You will be able to go back and add 
another learner group later on, if needed. 
1. The most common selection is “Social & Behavioral Research 
Investigators,” shown below. (Note: after enrollment, on My 
Courses page, the title will appear as “Social & Behavioral 
Research - Basic/Refresher.”)  
2. The Biomedical Research Investigators course can be selected 
for researchers that are conducting mostly biomedical research. 
 
 
f. Responsible Conduct of Research 
i. Visit Responsible Conduct of Research on the ORC website for 
guidance on when and for whom this training is required. 
ii. On Question 4, select “General Responsible Conduct of Research 
Course.” (Note: after enrollment, on My Courses page, the title will 
appear as “General RCR.”) 
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As a reminder, please note that you are only required to take the trainings for 
your specific area(s) of research compliance. If you are unsure of which trainings 
may be required for your research, please explore the resources available on the 
ORC website and reach out to the ORC for additional guidance as needed. 
 
V. Access CITI User Records and Reports 
a. Users can access training records and Completion Reports through the “My 
Records” link in the menu bar at the top of the CITI page. 
b. CITI will automatically alert ORC when you complete training, however there 
is a slight delay. ORC is also able to view in CITI when your training is 
complete. Please do not need to send copies of completion reports to ORC. 
i. If you require immediate assistance (i.e. you've just completed 
Financial Conflicts of Interest training and need access to PARS), 
please contact sponsored@maine.edu.  




APPLICATION COVER PAGE 
• KEEP THIS PAGE AS ONE PAGE – DO NOT CHANGE MARGINS/FONTS!!!!!!!!!  
• PLEASE SUBMIT THIS PAGE AS WORD DOCUMENT 
 
APPLICATION FOR APPROVAL OF RESEARCH WITH HUMAN SUBJECTS 
Protection of Human Subjects Review Board, 311 Alumni Hall 
 
(Type inside gray areas) 
PRINCIPAL INVESTIGATOR:          EMAIL:       
CO-INVESTIGATOR:           EMAIL:       
CO-INVESTIGATOR:           EMAIL:       
FACULTY SPONSOR:            EMAIL:       
  (Required if PI is a student):  
TITLE OF PROJECT:        
START DATE:          PI DEPARTMENT:       
 
STATUS OF PI:  FACULTY/STAFF/GRADUATE/UNDERGRADUATE       (F,S,G,U) 
 
 If PI is a student, is this research to be performed: 
 
  for an honors thesis/senior thesis/capstone?  for a master's thesis? 
  for a doctoral dissertation?    for a course project?  




Submitting the application indicates the principal investigator’s agreement to abide by the responsibilities outlined 
in Section I.E. of the Policies and Procedures for the Protection of Human Subjects.   
 
Faculty Sponsors are responsible for oversight of research conducted by their students.  The Faculty Sponsor 
ensures that he/she has read the application and that the conduct of such research will be in accordance with the 
University of Maine’s Policies and Procedures for the Protection of Human Subjects of Research.  REMINDER:  if 
the principal investigator is an undergraduate student, the Faculty Sponsor MUST submit the application to the 
IRB.   
 






FOR IRB USE ONLY     Application #        Review (F/E):       Expedited Category:       
ACTION TAKEN: 
 
 Judged Exempt; category        Modifications required?       Accepted (date)       
 Approved as submitted.  Date of next review:  by        Degree of Risk:       
 Approved pending modifications.  Date of next review:  by       Degree of Risk:        
 Modifications accepted (date):       
 Not approved (see attached statement) 
 Judged not research with human subjects 
 
 
 FINAL APPROVAL TO BEGIN         
       Date 
             10/2018 
August 2020 
 
IRB APPLICATION FORM INSTRUCTIONS 
DO NOT SUBMIT WITH APPLICATION 
 
Things to remember when completing the application cover page: 
• The principal investigator must have a UMaine affiliation. 
• Faculty sponsor required if the principal investigator is a student. 
• The title should describe the specific subject matter to be researched. If the study is 
funded, the title must match the grant/proposal. 
• The start date refers to when the research with human subjects proposes to begin, 
and should not be earlier than ten days from the date the application is submitted. 





• Please read and follow instructions; incomplete applications will be returned.  
• FACULTY SPONSORS: you are responsible for the quality of the application; do 
not approve an application that is incomplete or does not follow the instructions – it 
will be returned to you.  
• For undergraduate students, the application MUST BE SUBMITTED (EMAILED) 
BY THE FACULTY SPONSOR.  
• Type responses to points below; please include the nine major headings detailed below 
(e.g., Funding, Summary, Personnel, Participant Recruitment), but do not include the 
application instructions.  
• Page number entire document. PLEASE SUBMIT AS ONE DOCUMENT. The Cover 
page should be submitted separately (and kept as Word document), but the narrative of 
the application (items 1-9 below), with appendices (measures, recruitment materials, 
consent forms, etc.) should be one document. 




1. Funding: if the proposed study has been submitted for funding or is funded, please 
list funding agency and grant/proposal number, if known. Note that the title of the 
IRB application should match the title of the grant. If the study is not funded, state 
N/A 
 
2. Summary:  
Describe the rationale of the study in concise, non-technical language.  
• Although the IRB does not wish to receive grant/dissertation proposals, this 
section should include a description of the scientific significance and goals of the 
study, including background information and citations, to justify conducting the 
study. The background information should also explain the rationale for the 
choice of the particular participant population, as well as the use of specific 
measures and procedures.  
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• Include a methods section (with “Methods” heading). This section need not be 
long, but the IRB wants to understand early on how the study will be conducted. 
Some can be as brief as: “This study will involve face-to-face interviews at a 
location of the participant’s choosing. The interviews may take 45-60 minutes and 
will be recorded.” This section would be longer if there are many components of 
your study. 
• Include a reference page for the citations (we expect to see citations!). 
• Include questionnaires, interview questions, measures, etc., as appendices. 
 
2. Personnel: 
• Identify the person(s) named on the cover page (including the faculty sponsor, if 
applicable), as well as others who will have contact with the participants and/or 
with identifiable data. (NOTE: Make sure principal investigator is named; do not 
state: “I will be the principal investigator.” Be sure to define the roles that the 
named personnel will have in the research project. 
• Specify the affiliation/qualifications of everyone listed, e.g., “Jane Doe, Graduate 
student in the Department of Psychology, College of Liberal Arts and Sciences.” 
Briefly explain each person’s experience with research with human participants. 
Include the years of human subjects research experience for all personnel listed.  
• Everyone named in this section is required to have completed the human subjects 
training. 
 
3. Participant recruitment:  
• Describe the characteristics of the participant population. Describe the expected 
number of participants or the expected response rate (e.g., plan to send out 500 
surveys and expect 20% response rate). Include the age range of the participants 
and whether particular demographics and characteristics (e.g., state of health) are 
sought. If you are recruiting only one gender, explain why. (NOTE: if you are 
specifically recruiting members/citizens of the Penobscot Nation, please be sure 
to state they are your targeted population.) 
• Describe how the proposed number of participants was determined.  
• Describe participant identification and recruitment procedures, e.g., email 
(explain how are email addresses obtained), post flyers, etc. If you plan to recruit 
participants from another institution, please be aware that you may need to get 
permission from that institution to access participants and, if applicable, get 
approval from that institution's review board. Please note that if you are seeking 
participants with a specific physical or mental health condition, you CANNOT 
ask a professional services provider to give you a list of names of individuals who 
fit your criteria. However, these service providers may share your recruitment 
materials with those who appear to be eligible for your study, and interested 
individuals can contact you directly. Include (as appendices) recruitment letters, 
phone/email scripts, flyers, advertisements, postings, etc., that may be used to 
recruit participants (see samples on the IRB website). Reference the appendix 
number/letter. 
 
 Please note: The IRB requires special measures of protection for participants of 
diminished autonomy. (See Sections II, III, and/or IV from Policy.) Vulnerable 
populations must be treated with special sensitivity to their restricted ability to protect 
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themselves. The risks imposed by a proposed study involving such populations must be 
recognized and the benefits to be derived from participation must justify the risks. In 
certain instances, advocates must be appointed to protect the participants. Such 
populations include fetuses (and by extension pregnant women), patients, prisoners or 
parolees, minors (less than 18 years old), and mentally or physically challenged people. 
In addition, the IRB may require special measures to preserve the rights of participants 
whose circumstances may make them vulnerable to undue influence to participate in 
research. These may include, for example, students and employees of the University. 
State which, if any, of the above groups may be represented in your participant 
population, and justify their inclusion. 
 
4. Informed consent (See Sections I.K. and I.L. of Policy): 
• Describe the type of consent (oral or written) to be used and the means of 
obtaining it. Describe how and when potential participants will get the consent 
form.  
• If the participants are minors or mentally incompetent, describe the means of 
obtaining both the participants' assent (if feasible) and the consent of parents or 
legal guardians.  
• Include a copy (in an appendix at the end of the application) of the consent 
form(s) and assent scripts (if applicable). Consent forms should be written no 
higher than an 8th grade reading level.  
• Review the informed consent checklist and FOLLOW THE SAMPLE(s) 
FOUND on the IRB website Please note: The documentation (signature) of 
informed consent is not necessary for a project in one of the exemption categories. 
THE SAMPLE FORMAT, WITH HEADINGS, MUST BE FOLLOWED OR 
THE APPLICATION WILL BE RETURNED. 
 
5. Confidentiality:  
• Describe the precautions that will be taken to ensure privacy of the participants 
and the confidentiality of the data, both in your possession and in reports and 
publications (e.g., are responses anonymous, are responses coded with 
identification numbers and a key used to link names to identification numbers).  
• If data collection will occur on-line, state the program that will be used (e.g., 
Qualtrics, Skype, etc.). If applicable, state whether IP addresses will be collected 
(preferable that they are not collected!). State whether data will be downloaded 
off program to researcher’s computer, as well as the expected date data will be 
deleted off the program site. 
• State the location where data will be stored. Describe the disposition of the 
research data, including any audio, video, or film recordings, when the research is 
completed (define as expected date to be destroyed or kept indefinitely). If not 
keeping indefinitely, don’t say “kept until study completed,” or “when analysis 
completed,” etc. State an approximate date (month/year) of those occurrences, 
e.g., January 2024. If you are not keeping data indefinitely, be sure to be 
generous with a destruction date, so you don’t end up in a situation where 
you are not ready to destroy the data, but must because that is what you told 
the participant – NOTE: if you say you will keep the data indefinitely, you 
can destroy it at any time—but if you give an actual date, you must adhere to 
it!  
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• If recording, state whether a transcription service will be used or if named 
investigator(s) will transcribe. 
• If applicable, state whether the key is paper or electronic and where and how long 
the key will be kept (key should be kept separate from data). Keys are typically 
kept for a lesser amount of time than data are kept. Use a date for destroying the 
key, but give yourself plenty of leeway with the timing in case your project gets 
delayed. If you wish to keep the key indefinitely, please explain why, as it 
impacts participant confidentiality. If the key will be stored electronically, it must 
be encrypted. Please see information on encrypting electronic, identifiable data 
(the key linking names to data or entire dataset). 
• Assurance must be provided that all identifiable data will be secured under 
conditions that limit their access to the investigator(s) only.  
• If focus groups are used to collect data, the researcher should acknowledge that 
he/she cannot guarantee confidentiality of participants’ responses, but will 
encourage participants to not discuss responses outside of the focus group.  
• If the data are published, care must be taken to remove identifying references in 
order to preserve privacy.  
• The IRB recognizes that some studies, such as oral histories, do not require 
confidentiality of data. The regulations and the IRB are flexible – explain what 
will happen with the data. If applicable, explain why data will not be confidential. 
  
6. Risks to participants:  
• Describe in detail any possible physical, psychological, social, legal, economic, or 
other risks (including a risk of identification) to the participants, either immediate 
or long range. Do not state that there are no risks. All studies have risks (e.g., 
time and inconvenience).  
• If the participants will be exposed to greater than minimal risk, justify the use of 
the procedures and state reasons for not using a procedure that would entail a 
lesser risk.  
• Describe procedures used to minimize risk (e.g., assuring participants that they 
may skip questions they prefer not to answer). If applicable, include referrals to 
relevant resources from which participants could seek support. Use the Referral 
Handout Template and edit as necessary.  
• Describe what procedures will be followed if research procedures reveal that 
participants are at elevated risk (e.g., high blood pressure, clinical levels of 
depressive symptoms). See Guidance for Researchers – Depression and 
Suicidality in Human Research. 
 
 7. Benefits: 
• The description is two parts. (1) Describe the benefits of the research to the 
participants, if any (if no direct benefit to the participants, so state). NOTE: 
Money, course credit, gifts, etc., are not benefits; they are compensation.  (2) 




• If applicable, list any compensation for participation (money, course extra credit, 
raffle, etc.). Also indicate how compensation will be handled if a participant 
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withdraws from the study (e.g., no compensation, prorated compensation, or full 
compensation; must reach end of survey to enter raffle; must complete survey, 
except for the occasional skipped question, to enter the raffle, etc.). Regarding 
extra credit: if extra credit is offered, the course instructor must offer other 
methods of earning extra credit such that participating in the research is not the 
only way a student can earn extra credit. If a study involves several classes with 
different instructors, all must agree to grant extra credit and all must offer other 
methods of earning extra credit. Compensation shouldn’t just be for some of the 
participants.   
• For raffle/compensation for on-line studies (where the link to the 
raffle/compensation takes the participant to a new page to enter their contact 
information), include the text of that page as part of your application. It need not 
be long – thanking them for taking the survey, reminding them that their contact 
information is not linked to their survey responses, along with place for 
name/email/phone, etc.  
• If the value of a one-time payment exceeds $75.00, subject data must be reported 
to other offices within the University of Maine and University of Maine System, 
as follows: 
 
o If the human subject is an employee of the University of Maine, the 
researcher must report any such payments to the Department of Human 
Resources. The Department of Human Resources will determine whether 
the value of the reported incentive needs to be added to the employee’s 
gross wages, and whether the payment will be subject to taxation and 
withholding. 
 
• If the human subject is not an employee of the University of Maine, the 
researcher shall report any such payments to the Department of Purchasing. 
The researcher will work with the Department of Purchasing to comply with 
IRS regulations that require the University of Maine System to issue a Form 
1099 when cumulative payments to a non-employee reach $600 in a calendar 
year. 
 
SEE Consent Guidelines for the wording to be used in the consent form. 




Submission Instructions:  
 
• Email complete application and cover page to umric@maine.edu).  
 
• REMEMBER – If an undergraduate is the principal investigator, the faculty 
sponsor must submit the application. 
 
• The submission email should have two attachments: 
1) The completed cover page as Word document.  
2) The narrative of the application (items 1-9 above) along with the appendices -- 
consent form(s), recruitment materials, measures, etc. as ONE document – 
PAGINATED.  
 
• Please note that the IRB expedites many applications (reviews outside of a full board 
meeting). The IRB will expedite applications when possible, typically within ten business 
days. The IRB will make the final determination of whether your study is eligible for 
expedited review.  
 
• If your study involves sensitive topics, protected populations, and/or more than minimal 
risk, the application may require full board review. In those cases, the application is due 
by the first Friday of the month for inclusion on the agenda for that month.  
 
 
Please contact the IRB if you have questions – 207-581-2657 or e-mail umric@maine.edu. 
 
 
  December 2010/OSR 
Request for Student Data for Use in Research Project 
 
Documentation of IRB Approval Attached? ___________ 
Faculty Approval:             
Office of Student Records Approval:           
The student and the  faculty member will be notified of the approval status of their request. 
 
Purpose of Project:               
Data Requested:  _________________  __      
              
              
How will the data be stored (electronic & paper): ______________________________  _____  




Name:                
Department:    ____________  ________      Phone: ___________________________  
Faculty Advisor (if applicable):            
Signature: _____________________________________________       Date:  _______________________  
Approval 
All requests must be in accordance with FERPA regulations and have Institution Review Board for Protection 
of Human Subjects (IRB) approval.  If this is a project that a student is conducting, there must be a faculty    
advisor that approves the data request. 
Storage of this data, either electronic or paper, must be in a secure location and not shared with a third   
party. 
SAMPLE ASSENT SCRIPT 
 
For studies involving children, an assent script is required. Children with permission to 
participate in a research study also have the right to be informed about the study and choose 
whether they wish to participate. Create a script that describes the study, what they’ll be asked 




Below is a very basic sample script, one that could be used with most young children. For middle 
school children, you may include more information and increase the reading level slightly. We 
suggest you test your assent script on children you may know to see if they understand what you 
are asking. For high school students under 18, it is acceptable to use the parent/guardian consent 




Hi, my name is ____________________, and I’m from the University of Maine. I am here today 
because I am doing a project to learn about ______________________. 
 
I would like to ask you to _______________ (explain in very simple language the activities the 
child will be asked to do). If you say “yes,” you can still stop at any time by just telling me you 
want to stop. No one will be upset if you don’t want to do this, or if you want to stop after you 
have started. If I ask you a question and you don’t want to answer it, that’s ok. Your parents have 
said it is ok for you to be in the project if you want to. 
 
Your answers will be private and only used for my project. 
 
Would you like to be in my project? 
 
 
NOTE: Depending on the type of study, additional information may be required, e.g., “some 
questions could make you sad” (risk statement). 
 
SAMPLE CONCISE SUMMARY 
With the Revised Common Rule that went in effect in January 2019 studies with longer consent forms 
or Federally funded studies a concise summary is required. 
The concise summary is meant to be brief. The purpose of the summary is for the participant to decide 
why he/she may want to participate but should also include information on why he/she may not want to 
participate in the study (for example a huge time commitment or other risks). The summary should not 
include all foreseeable risks but the risks that would be most likely or most severe to the participant. 
The summary should include the following 5 elements: 
1) A statement that the project is research and that it is voluntary. 
2) A summary of the research (purpose, overview of procedures etc.) 
3) Any foreseeable risks or discomforts 
4) Any expected benefits to participants (if applicable) 
5) If applicable, alternative procedures to course of treatment 
CONCISE SUMMARY EXAMPLE – Biomedical (non-drug/device study) 
You are being asked to join a research study. The research is to help……. 
Before you consider the research you should be aware of the following information: 
 Research is voluntary. You do not have to be in this study. 
 The study will require 2 visits to the lab for 2 hours (total time of 4 hours). 
 We will ask you questions about your health. 
 The study involves a blood draw to collect biomarker information and exercise testing. 
 If you think you want to be in the study, you should read the rest of this document. The 
document explains what will happen to people in the study 
CONCISE SUMMARY EXAMPLE – Social and behavioral 
You are being asked to join a research study. The research is to help……. 
Before you consider the research you should be aware of the following information: 
 Research is voluntary. You do not have to be in this study. 
 You will complete pre-screening surveys about your mental and physical health. 
 You will have your blood pressure and heart rate measured. 
 If after the screening you qualify for the study, you will return to the lab to complete some 
challenging mental stress tests. This part will be videotaped. 
 The pre-screening will take 1 hour in the lab and the study will take 2 hours in the lab. 
  If you think you want to be in the study, you should read the rest of this document. The 
document explains what will happen to people in the study 
SAMPLE CONSENT FORM FOR ANONYMOUS ELECTRONIC SURVEY 
 
 
 You are invited to participate in a research project being conducted by (name), a (faculty 
member, staff member, graduate student, undergraduate student) in the Department of (name) at 
the University of Maine.  If the principal investigator is a student, also name the faculty sponsor 
and his/her department.  The purpose of the research is _______________________________.  
You must be at least 18 years of age to participate.  The age statement is not always required.  
An example of when it is required is if the study involves the UMaine undergraduate student 
population.  If there is a chance that someone in the population you are studying could be under 
18, include the statement. 
 
What Will You Be Asked to Do? 
 
 If you decide to participate, you will be asked to take an anonymous survey.  It should 
take you about X minutes to complete.   
 
Risks:    
Note that there is always some risk, at minimum the participant’s time and inconvenience. Listed 
below are examples.   
 
 
- Except for your time and inconvenience, there are no risks to you from 
participating in this study. 
 
OR 
- There is the possibility that you may become uncomfortable answering the 
questions.  You may skip any questions that make you uncomfortable.  Provide 
referral resources if questions very sensitive, e.g., depression, suicide, etc.  
Referral resources may include UMaine Counseling Center (if UMaine students), 
National Hotlines, etc.  Either mention the resources within the consent, or link to 
resource information (see referral handout).. 
  
Benefits (Two benefit statements are required – benefit to participant (if any) and potential 
benefit of the research) 
 
(Most surveys do not have a benefit to participants) 
 




Compensation:  Listed below are examples; if you are not offering compensation, leave this 
section out.  NOTE:  See Item #7 on checklist for additional guidance if 
compensation exceeds $75. 
 
 - You will receive $X for participating in this study.  
 - You may enter a raffle to win one of two $25 Amazon gift cards.   
- You will receive 1 hour of research credit (or other wording for extra credit) for 
participating in this study. 
 
 Confidentiality  
 
 This study is anonymous.  Please do not write your name on the survey.  There will be no 
records linking you to the data.  Data will be kept on a password-protected computer indefinitely.  




 Participation is voluntary.  If you choose to take part in this study, you may stop at any 
time.  Explain whether stopping will alter compensation to be received, e.g., “… stop at any 
time, but you must reach the end of the survey to enter the raffle; “While you may skip the 
occasional question, you must complete the survey to be eligible for compensation.”  You may 
skip any questions you do not wish to answer. 
 




 If you have any questions about this study, please contact me at (phone, e-mail).  You 
may also reach the faculty advisor on this study at (phone, e-mail).  If you have any questions 
about your rights as a research participant, please contact the Office of Research Compliance, 
University of Maine, 207-581-2657 (or e-mail umric@maine.edu). 
 
SAMPLE CONSENT FORM 
(Use in conjunction with the checklist!) 
 
 
 You are invited to participate in a research project being conducted by (name), a 
(faculty member, staff member, graduate student, undergraduate student) in the Department 
of (name) at the University of Maine. If the principal investigator is a student, also name 
the faculty sponsor and his/her department. The purpose of the research is 
_______________________________. You must be at least 18 years of age to participate. 
The age statement is not always required. An example of when it is required is if the study 
involves the UMaine undergraduate student population. If there is a chance that someone 
in the population you are studying could be under 18, include the statement. There may 
need to other inclusion criteria listed, such as “You must be between 50-75 and have 
suffered a stroke in the last two years.” 
 
What Will You Be Asked to Do? 
 
 If you decide to participate, you will be asked to (describe procedures, give 
examples of sample questions if applicable). If the study involves a focus group, indicate 
how many people will be in the group. If an interview or focus group will be recorded, state 
that in this section. It may take approximately (amount of time) to participate. If the 
procedures are numerous, we suggest you use bullets to make the form easier to read. 
 
Risks:  
Note that there is always some risk, at minimum the participant’s time and inconvenience. 
Listed below are examples.  
 
 
- Except for your time and inconvenience, there are no risks to you from 
participating in this study. 
 
OR 
- There is the possibility that you may become uncomfortable answering the 
questions. You may skip any questions that make you uncomfortable. 
Provide referral resources if questions very sensitive, e.g., depression, 
suicide, etc. Referral resources may include UMaine Counseling Center (if 
UMaine students), National Hotlines, etc. Either mention the resources 
within the consent, or reference an attachment with resource information. 
 
 
Benefits (Two benefit statements are required – benefit to participant (if any) and potential 
benefit of the research) 
 
 
- While this study will have no direct benefit to you, this research may help us 
learn more about… 
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- You may learn how your energy level changes your mood. In addition, this 
research may help us learn more about… 
 
- You will have a cholesterol screening at no charge. In addition, this research 
may help us learn more about… 
 
 
Compensation: Listed below are examples; if you are not offering compensation, leave this 
section out. NOTE: See Item #7 on checklist for additional guidance if 
compensation exceeds $75. 
 
 - You will receive $X for participating in this study.  
- You will receive $X for completing the first part of this study and $X for the 
remaining part. 
 - You will receive 1 hour of research credit for participating in this study. 




Sample for when data are confidential, i.e., names are connected to data, typically by use of 
a code/key. NOTE: this is a sample; it may not fit your study. The important aspect is to tell 
people how the data will be kept to ensure confidentiality and how long it will be kept – or 
to inform that that it won’t be kept confidential, as in the case with some studies (e.g., oral 
histories). 
 
 Your name will not be on any of the data. A code number will be used to protect 
your identity. A key linking your name to the data will be kept separate from the data in a 
locked office (if paper) and destroyed by XXXX (date). If a key will be kept electronically, 
explain that it will be stored on a password-protected computer using software that 
provides additional security. Data will be kept on a password protected computer and kept 
(indefinitely or destroyed by date). Specifically address the retention of any audio, video, or 
film recordings. List others who may have access to data, such as faculty advisor and/or 
others working on the project. If a transcription service will be used (instead of named 
researchers), include that information. Your name or other identifying information will not 
be reported in any publications (statement not needed for anonymous studies). 
 
For Focus Groups, also include this statement: Due to the group format, I cannot guarantee 





 Participation is voluntary. If you choose to take part in this study, you may stop at 
any time (explain whether stopping will alter the benefit or compensation to be received). 






 If you have any questions about this study, please contact me at (phone, e-mail). 
You may also reach the faculty advisor on this study at (phone, e-mail). If you have any 
questions about your rights as a research participant, please contact the Office of Research 
Compliance, University of Maine, 207-581-2657 (or e-mail umric@maine.edu). 
 
If the study is not exempt from further review, continue with the following statement. 
 
 Your signature below indicates that you have read the above information and agree 
to participate. You will receive a copy of this form. 
 
 
_____________________________________  ________________ 
Signature       Date 
 
 
NOTE: If your study involves children (<18 years old), the consent letter is written to Dear 





EMAIL RECRUITMENT TEMPLATE ELECTRONIC SURVEY 
Greetings, 
You are invited to participate in a research study.  The research is being conducted by (name, 
title, Department at the University of Maine).  Say how the participant’s contact information was 
obtained for example: John Doe suggested I contact you or I found your contact information on 
“Z” website. NOT needed if posting an email on listserve, Facebook, etc.).  State the purpose of 
the research. Insert age requirement, for example: you must be at least 18 years old to participate 
(not needed if you know your targeted population is at least 18) or you must be between ages 
____ to participate.  Include any other applicable inclusion/exclusion criteria. 
If you agree to participate, you will be asked to take an anonymous/confidential (state one or the 
other!) survey. The survey will take approximately (state how much time it will take).  If there is 
compensation you should add that information in the recruitment email. 
Please click on the link below to learn more about the study and to take the survey (insert survey 
link – FYI the first page of the survey will be the consent form). 




General Email Posting (listserves, Facebook, University folders, etc.): 
You are invited to participate in a research study.   The research is being conducted by (name, 
title, Department at the University of Maine).  Insert age requirement for example: you must be 
at least 18 years old to participate (not needed if you know your targeted population is at least 
18) or you must be between ages ____ to participate. Include any other applicable 
inclusion/exclusion criteria. 
I am conducting a research study about (insert purpose of research). If you agree, you will be 
asked to (briefly describe procedures, including time commitment, location, any recording – 
audio/video).   
If you would be interested in participating in this study, please contact me (provide contact 
information).   
Thank you. 
  
Phone Script (interview over the phone/in-person): 
Hello, my name is (name) and I am a researcher at the University of Maine. Say how 
participant’s phone number was obtained.  I am conducting a research study about (insert 
purpose of research). I am calling to ask if you would be willing to let me interview you. The 
interview can be conducted over the phone or at a location of your choosing.  The interview 
should take (insert time interview will take).  Say if the interview will be recorded. Insert age 
requirement, for example: you must be at least 18 years old to participate (not needed if you 
know your targeted population is at least 18) or you must be between ages ____ to participate. 
List any other applicable inclusion/exclusion criteria.  
If you would be interested in participating in this interview, we can set up a time now or you can 
let me know when a good time would be to schedule it. 
If interested, investigator will set up date and time and will provide participant with investigator 
contact information. For example: I have scheduled you for an interview on (date and time). If 
you have any questions, I can be reached at (insert phone number and email). Thank you for 
your help. 





My name is (name) and am a researcher at the University of Maine. Say how participant’s 
contact information was obtained.) I am conducting a research study about (insert purpose of 
research).  
I am contacting you to ask if you would be willing to participate. Participation would involve 
(briefly explain what they will be asked to do and where it takes place).  Insert age requirement 
for example: you must be at least 18 years old to participate (not needed if you know your 
targeted population is at least 18) or you must be between ages ____ to participate.  List any 
other applicable inclusion/exclusion criteria.   
If you would be interested in participating, please reply to this email/contact me (provide contact 
information).   
Thank you for your time. 
 
 
You are invited to participate in a research study about (add 
research topic). 
Give name of PI(s), Title, and Department at the University of Maine. 
We are looking for individuals (add age requirement here) who would want to participate in an 
(recorded, if applicable) interview. If in person, give a location or say over the phone. The 
interview may last between (give time it will take). If there is compensation and/or 
refreshments it should be listed in the announcement. 
All information shared in the interviews will remain confidential. 
If you would like to participate and/or have questions about 
this study, please contact (add name, phone and email). 
INVITATION TO PARTICIPATE 
IN A UNIVERSITY OF MAINE 
RESEARCH STUDY 
SAMPLE SONA RECRUITMENT SCRIPT 
Study Name: Recruitment Messages and Course Selection 
Type: Online  
Credits: 1 credit 
  
Description: 
We are working to understand how college admissions view books are related to the desire to 
take courses or participate in a certain major. You will be randomly assigned to view either 
captions or photos from a certain major. We will ask you a series of 
questions concerning your beliefs, interests, and other personal factors. You must be 18 years of 




Guidance & Policy 
Regulations 
Training 




Deadlines for Submission of Applications for Approval 
For submission of applications, the Protection of Human Subjects Review Board (IRS) has 
a standard deadline date of the first Fr iday of every month. An application submitted on 
the fi rst Fr iday of the month will be reviewed at that month's meet ing (the IRB typically 
meets during the 3rd week of the month). 
An investigator may request an expedited review of his/her application if the proposed 
research activity is w ithin one of the categories eligible for expedited review. Applications 
requesting expedited review may be submitted at any time. The IRB aims to review and 
send comments back to investigators w ithin ten working days. 
Please contact the IRB office if you have questions. 




Guidance & Policy 
Regulations 
Training 






• Deadlines: The deadline for submitting applications for approval is the first Friday of 
the month. 
• IRB MembershiP- Ust 
• What is HIPAA? 
Useful Links 
• Considerations and Recommendations Concerning Internet Research and Human 
Subjects Research Regulations (PDF) 
• Federal and State Regulations & Guidance Materials 
• Human Subject Regulations Decision Charts 
• Public ResP-onsibili!.Y. in Medicine and Research (PRIM&R}. (Mission: Since its 
founding in 1974, Public Responsibility in Medicine and Research (PRIM&R) has been 
committed to the advancement of strong research programs and to the consistent 
application of ethical precepts in bot h medicine and research. Through national 
conferences and published reports thereon, it has addressed a broad range of 
issues in biomedical and behavioral research, cl inical practice, ethics, and the law. 
D @) 
Apply Student Resources Nond1scnm1nauon notice Clery Safety and Secunty Report COV!0 -19 health and .safety guidance Emergency 




Guidance & Policy 
Regulations 
Training 






Q. What is the IRB? 
IRB is the acronym for the Institutional Review Board for t he Protection of Human 
Subjects. The IRB reviews all research conducted by facu lty, staff and st udents that 
involves human subjects. The purpose of the IRB is to ensure that research with human 
subjects is conducted ethically. The IRB ensures that the r isks to participants are 
minimized, that selection of participants is equitable and that participants are informed 
about what participation in the study w ill entail. 
Q. What is considered research by the IRB? 
A systematic investigation, including research development, testing and evaluation, 
designed to develop or cont ribute to generalizable knowledge. 
Q. What is the difference between consent and assent? 
Consent: Can only be given by a compet ent individual who is of legal age and has been 
given sufficient information about the purpose of the study, t he benefits and r isks of the 
study. 
Assent: Agreement of a minor to participate in a research study. Assent MUST be 
accompanied by informed consent of the minor's parent or legal guardian. 
Q. What is the d ifference between compensation and benefits? 
Compensation: Is a payment or reimbursement of the participant's time or expense. This 
can even be class credit. 
Benefits: Is something that can be related to or resulting from research efforts. Could be a 
benefit to the subject or to society. 
Q. What is the d ifference between anonymous and confidential data? 
Anonymous means that you are not collecting any identifying data from the subjects and 
that you will have no means to contact or follow-up w ith the subjects. 
When data is confidential, identifiable data will be collected and the researcher can 
identify the subject. In this case the subject could be contacted for follow-up procedures. 
COVID and IRB Applications: 
Q. Where can I find information about research and current COVID restr ictions? 
See official information about the University'. of Maine P-Olic ies on restr ictions on research. 
Q. What modifications should I make to my applicat ion? 
The researcher should first review the University'. of Maine COVID-19 guidance for 
researchers. You should modify any in-person research visit that does not have to be 
conducted on-site to a remote visit. These changes will require a modifi cation submission. 
Q. Are there COVID changes that do not require a modification? 
The IRB has determined that these activities are not considered a 'change to the research' 
and therefore do not need to be submitted as modifications to research protocols: 
• General communications with subjects about COVID-19. These are not study-specific 
communications, but rather are providing information that is publicly available, e.g., 
on the University of Maine website or CDC recommendat ions. 
• Screening procedures for COVID-19 infection consistent with procedures on the 
University: of Maine COVID-19 guidance for researchers. These are not study-speci fic 
procedures. 
Initial Submissions: 
Q. What documents do I need to submit with my in it ial submission? 
This w il l vary depending on your study but in genera l you will need to submit a cover 
page and an application that includes the narrative, measures you w ill administer, 
recruitment script(s), consent form(s) and assent script (for studies with participants 
under 18 years old). 
Initial submissions should be as complete as possible but we understand that 
submissions aren't perfect from the start (especially if it is your first submission). Prepare 
what you believe is needed, and the IRB Office will let you know of any changes or 
additional documents that are needed for your IRIB review. 
Q. My study is Quality Improvement; do I need to submit an application? 
If your project involves human subjects or their data, the best practice is to check with the 
IRB to confirm if I RB oversight is required, even if you think your project is Quality 
Improvement or Quality Assurance. You may simply provide a br ief explanation of your 
study along w ith some sample measures to umric@maine.edu and the I RB will let you 
know if an application is required. 
Q. Which consent template should I use? 
We have several consent form tem12lates on the IRB website to choose from. Select the 
templat e you believe is appropriate, and the IRB Office will let you know if something 
d ifferent is needed once they start their review. 
Q. Does my project need IRB review? 
The project must be research and involve human subjects to need IRB review. Please do 
not attempt to determine for yourself that your project is not research involving human 
subjects. You should have the IRB make t his det ermination. 
The Common Rule defines "research" as a systematic investigation, including research 
development, testing and evaluation, designed to develop or contribute to generalizable 
knowledge. 
Systematic is an act ivity that follows a written plan and adheres to scientifically accepted 
principles for research design to answer a question. Examples of some activities are 
surveys, interviews, review of medical charts. 
Generalizable knowledge is defined as knowledge from which conclusions will be drawn 
that can be applied to populations outside of the specific study population. The results 
are expected to be generalized to a larger population beyond the site of data collection; 
the results are intended to be replicated in other settings. 
The Common Rule defines a human subject as a living individual about whom an 
investigator conducting research obtains (1) information or biospecimens through 
intervention or interaction w ith the individual, and, uses, studies, or analyzes t he 
information or biospecimens; or 45 CFR 46.102(e) (2) uses, studies, analyzes, or generates 
identifiable private information or identifiable biospecimens. 
Q. When should I submit my application? 
If your study is exempt or can be expedited you should submit your application at least 
30 days before you intend to start your research. This allows the IRB time to review it and 
it will you give t ime to make any changes requested by the IRB in a timely manner and stil l 
meet you start date. For Full Board review, your proposal should be submitted by the 
submission deadline listed on the IRB website. 
Q. What should be my consideration if I am using Zoom for my study? 
You should create a private meeting with a unique meeting ID and password. To protect 
the privacy of the participants, consider using only audio and not video recording. Learn 
more about Zoom guidance for IRB studies. 
Q. What information should be included in the recruitment mater ials? 
The recruitment scripts must have sufficient information so potential participants can 
make an informed decision about participation. The following items must be included: 
• The name and contact information of the Pr incipal Investigator. 
• The purpose of the research. 
• The time commitment required of subjects. 
• The location of the research. 
• A clear statement that it is a research project. 
• A clear statement that it is voluntary. 
IRB Approvals:. 
Q. My research w ill be done in another country. Do I need IRB approval from the 
University of Maine? 
Yes, you must get approval from the IRS at the Un iversity of Maine. You should also be 
aware that you many need approval from an IRB or ethics committee from the country 
where you w ill be conducting the study, so please plan accordingly. 
Q. Do I need approval from the IRB even if my study if not funded? 
Yes, you must obtain IRB approval from the University of Maine regard less of funding. 
Q. May I begin recruitment of subjects while IRS approval is pending? 
No, you need IRB approval BEFORE recruitment or study enrollment begins. 
Q. Do I need to submit an IRB application if I am not collecting any identifying information 
in my research project? 
Q. Can the IRB approve a research study retroactively? 
No, there is not provision in the Federal regulations that allows the IRB to approve a study 
that has already been conducted. This is why it is so important to check with the IRB if 
approval is needed before you start a research study. 
Q. What if I am not sure if my activity needs I RB review? 
Email a brief summary of the activity to umric@maine.edu and the IRS w ill respond with a 
determination. 
Q. If I submit a grant proposal do I have to submit an IRB application at the same time? 
You can submit the IRB application at the same time as the proposal. Depending on the 
sponsor you may also submit the IRB application at the time of award. We st rongly 
encourage you to check w ith the sponsor on their requirements. 
Principal Investigator and Study Team Management: 
Q. I am leaving the University; what happens to my IRB study? 
The Pl should close out the applications or notify the Office of Research Compliance in 
writing that the study w ill be t ransferred to another quali fied Pl at the University of 
Maine. 
Changes in t he Pl should be submitted to the IRB prior to the new Pl assuming oversight 
of the study. The change must be submitted at least 14 business days pr ior to the 
departure of the former Pl. If the former Pl is leaving the institution but will remain a 
study team member, please contact the IRB office. See "How do I submit a change in Pl?" 
below. 
If the study is funded the Pl should also notify the Office of Research Administration. 
Q. How do I submit a change in Pl? 
The change in Pl should be submitted as a modification. The request will be reviewed at a 
Full Board meeting unless the original study was expedited and continues to meet criter ia 
for review under expedited procedures. 
The research team should consider whether study documents are affected by the change 
in Pl, such as the consent forms and recruitment mater ials. If participants are still 
enrolled in the research study, the IRB recommends that the research team provides a 
written update to the participants, such as an information sheet or letter, to inform them 
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(e.g., for study-related quest ions). 
Q. What is the faculty sponsor's role for student projects? 
The main expectation is that the sponsor assists st udents during the IRB process. The 
sponsor must review t he application before submission to ensure that the application is 
thorough and accurate. The faculty sponsor must also monitor the st udents during the 
study to ensure t hat the student is following the procedures described in the application 
and that if any unexpected or adverse events occur they are promptly reported to the IRB. 
If the Faculty Sponsor is leaving the institution and the study is still active another 
qualified Faculty Sponsor must be appointed; see "How do I submit a change in Pl?" 
above. 
Q. How do I add study personnel to my approved IRB study? 
If you simply need to update personnel on an approved study, you do not need to edit 
the approved application. An email to umric@maine.edu referencing the st udy title and 
number along w ith name of person(s) to be added, years of human subject s research 
experience, role on the project, and email is sufficient. If the CITI train ing was not 
completed through UMaine please also provide the CITI t ra ining certifi cate. 
Some personnel changes may also require a change to other sections of the application 
such as the consent document, and recruit ment mater ials. In such cases, the application 
should be modified to include these changes and submitted as a modification for review. 
Q. Who should be listed as study staff on the applicat ion? 
All study staff members who are reasonably engaged in t he design, conduct or analysis of 
the study should be listed in t he application. If the sta ff or st udents w ill have direct 
contact with subjects or access to subject ident ifiable data, they must be listed in the 
application. The person must also have completed all the re~uired IRB training. 
Q. Do all personnel have to be listed on the consent form? 
No. The Pl must be listed on the consent form. Beyond that, we suggest no more t han 3 
people the research participant is most likely to encounter during the conduct of the 
study. 
Co-Investigators are not required to be l isted on the consent form. 
Ongoing Study Management: 
Q. How do I submit a continuing review? 
You will need to submit the continuing review form that was emailed t o you along with 
the status report and consent forms to umric@maine.edu. If you are also requesting a 
modification, you w ill also need t o submit the edited application and fo llow the 
modifi cation instructions on the IRB website. Do not wait until the Study Expiration date 
to submit your continuing review, as the study will very likely enter lapse state. 
Q. I did not submit my cont inuing my review and my study has lapsed, what does this 
mean? 
The IRB Office sent you reminders for a continuing review and you did not respond to the 
IRB. Please submit the continuing review documents or study closure immediately. 
Research act ivities must stop while the study is lapsed. This includes recruitment, 
consent, interactions w ith participants, and collect ion of data. Advertisements currently 
running in the media must be pulled. Data collected during a lapse in IRB approval cannot 
be used. Continuation of research activit ies w ithout IRB approval is a violation of federa l 
regulations. 
Q. When should I close my IRB application? 
When all research activit ies are complete. We recommend you keep your study open until 
j ournal manuscripts have been submitted and accepted, just in case further data analysis 
is needed. 
Q. Do I need to report to the IRB when a study is completed? 
Yes, the regulat ions require "prompt reporting to the IRB of changes in research activity." 
Completion of a study is a change in activity and should be reported to the IRB. 
Q. Can I reactivate a previously closed study? 
Yes. See Reactivating a Closed Study for guidance. 
Working with Outside IRBs: 
Q. Will the University of Maine rely on a foreign IRB? 
We w il l not rely on an IRB that is outside of the United States. 
Q. What is the d ifference between Single, Reviewing and Relying IRB? 
Single IRB: One I RB of record (also called Reviewing I RB), selected on a study-by-study 
basis, that provides the regulatory and ethical review for all sites participating in a 
multisite study. 
Reviewing IRB: The IRB providing regulatory oversight (IRB of Record) for any participating 
sites that have waived oversight to this IRB. 
Relying IRB: The IRB of a participat ing site that has waived regulatory oversight to another 
IRB (the Reviewing IRB). 
IRB Required Training: 
Q. Federal regulations require that all researchers receive ethics train ing. How do I meet 
this requirement? 
All staff, students and faculty who submit an application for IRB review must complete the 
online CITI training. 
Q. What if not all personnel have completed CITI training but I rea lly need to get started 
on my research? 
That is okay. You can submit the application w ith just those people that have completed 
the training and get approved to start your research. Once additional personnel complete 
the training, you can submit an email to umric@lmaine.edu requesting to add those 
individuals, following the inst ructions to re~uest a modification to a P-reviously....s!P-P-roved 
study. 
Q. I completed the CITI Responsible Conduct in Research (RCR) course. Does this meet the 
IRB training requirement? 
No. All personnel must complete the Social/Behavioral or Biomedical IRB course. See 
instructions for selecting the correct IRB training. 

